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INTRODUCTION 
Abnormal vaginal discharge is a common clinical problem causing 
distress among reproductive age group women. Genitourinary symptoms 
in women usually lack specificity1. All women of reproductive age group 
have vaginal secretions, but they do not generally have the ability to 
discriminate normal from abnormal discharge. Some meticulous women 
may consider even normal physiological vaginal discharge to be 
abnormal while some ignorant women may disregard pathological 
vaginal discharge to be normal. 
Abnormal vaginal discharge is fairly common and results from a 
variety of infectious and non-infectious causes. Infectious vaginal 
discharge can be caused by bacterial, viral, fungal or parasitic infections, 
the three most common causes being Bacterial Vaginosis (BV), 
VulvoVaginal Candidiasis (VVC), and Trichomoniasis2.  
Gonorrhoea and Chlamydia affect only the cervical columnar 
epithelium causing cervicitis but may cause vaginitis when the stratified 
squamous epithelium of vagina is damaged due to other predisposing 
causes. Some viral infections like Human Papilloma virus (HPV), Genital 
Herpes Simplex Virus (HSV) can also cause vaginitis and vaginal 
discharge. Syphilis is an ulcerative sexually transmitted disease caused by 
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treponemes which can also cause vaginal discharge if any vaginal ulcer is 
present. 
Aerobic vaginitis is also seen in a small proportion of women 
caused by facultative anaerobic or aerobic bacteria mostly belonging to 
S. aureus, Group B Streptococci, Enterococci, E.coli and Klebsiella spp. 
Non- infectious causes of abnormal vaginal discharge are many 
including an idiopathic condition known as desquamative inflammatory 
vaginitis (DIV), chemical irritants, vulvovaginitis associated with 
estrogen deficiency and other gynaecological conditions. 
Abnormal vaginal discharge due to sexually transmitted infections 
is more common in women with high risk behavior (those having 
multiple sexual partners) than in normal women of reproductive age 
group. The common etiologies of vaginal discharge can also vary 
between the two groups of women.  
Infection of the genito-urinary tract if left untreated or if 
inappropriately  treated can lead to serious complications like pelvic 
Inflammatory disease (PID) that causes salpingitis, endometritis and 
tubo-ovarian abscess leading to scarring of the fallopian tubes. This 
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increases the risk of ectopic pregnancies, infertility, abdominal 
discomfort and chronic pelvic pain.  
Genito-urinary infections cause increase in risk of invasive cervical 
cancer, cystitis, ascending pyelonephritis, pyrexia of unknown origin and 
most importantly increased susceptibility to HIV transmission.3 Toxic 
Shock Syndrome by gram positive bacteria like Staphylococcus and 
Streptococcus spp. is especially associated with prolonged tampon use 
and lack of proper genital hygiene. 
Genito-urinary infections in pregnancy can lead to increased risk of 
chorioamnionitis, Premature Rupture of Membrane (PROM), preterm 
labour, Intra-Uterine Growth Retardation (IUGR), Intra-Uterine Death 
(IUD), spontaneous abortions and repeated miscarriages.4 
STI has an adverse consequence in the health of both mother and 
newborn. Vertical transmission of HIV, Congenital syphilis, Ophthalmia 
Neonatorum, Neonatal herpes simplex virus (HSV), Mental Retardation 
and delayed milestones are some of the serious problems in the child 
which can be prevented by treating the mother during pregnancy.  
           Identifying the etiological agent through laboratory methods and 
then administering appropriate treatment to the patient will help to 
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prevent such complications. But as this is not always possible in sexually 
transmitted infections patients due to loss of follow up, in many cases an 
empirical diagnosis is made and syndromic management is given to the 
patient and contacts. This syndromic management being presumptive can 
sometimes be inaccurate leading to treatment failure. 
On the other hand, many women with vaginal discharge self-treat 
with over-the-counter drugs making the pathogen more resistant to 
treatment. So, it is of great importance to determine the causative agent 
and give appropriate treatment to the patient to avoid complications and 
prevent unnecessary over-usage of drugs. 
Abnormal vaginal discharge being easily diagnosable and treatable, 
these serious complications can be avoided to a great extent. This study is 
undertaken to address these issues and determine the etiological diagnosis 
of abnormal vaginal discharge to give appropriate treatment to the 
patient.  
  
AIMS  
AND  
OBJECTIVES 
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AIM 
To determine the infectious etiology of abnormal vaginal discharge 
in women of reproductive age group attending Gynaecology OPD in 
Govt. RSRM Hospital and Sexually Transmitted Diseases OPD  in Govt. 
Stanley Medical College  
OBJECTIVES: 
1. To determine the pathogenic organism causing abnormal vaginal 
discharge in  women of reproductive age group attending 
Gynaecology OPD in Govt. RSRM Hospital and Sexually 
Transmitted Diseases OPD  in Govt. Stanley Medical College. 
2.  To make a comparison between the etiologic agents in the two 
groups i.e. between women in general population having abnormal 
vaginal discharge and women in High Risk Groups (HRG) having 
abnormal vaginal discharge. 
3.  To study the demographic profile and predisposing factors in 
women presenting with abnormal vaginal discharge. 
4.  To make a comparison between Amsel’s criteria and Nugent’s 
criteria for Bacterial Vaginosis. 
5.  To determine the prevalence and role of Candida albicans and Non 
albicans Candida species in Vulvo-Vaginal Candidiasis. 
REVIEW  
OF  
LITERATURE 
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REVIEW OF LITERATURE: 
EPIDEMIOLOGY: 
Sexually transmitted diseases (STD) refers to clinical syndromes 
caused by organisms that are acquired or transmitted through sexual 
contact.5  Sexual transmission occurs when one person harboring the 
infectious agent engages in sexual practice with another person who is 
susceptible to that agent.  
The term STD has widely replaced the earlier term venereal 
diseases (VD), a name derived from Venus, the goddess of love of the 
ancient Romans. STDs have been known to mankind from time 
immemorial. The first ever recorded case of STD occurred in ancient 
Greece, where the Herpes virus got its name meaning "to creep or crawl". 
Shakespeare referred to Herpes as "blister plagues", which shows the 
extent of the epidemic.  
Abnormal vaginal discharge  as a separate disease was described in 
ancient Thai medicine called ‘Muttakit’ and categorized into 4 groups 
resembling Bacterial vaginosis, cervicitis, carcinoma of cervix or 
endometrium with herbal cures for each group6. 
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Hippocrates described vaginal discharge “leucorrhoea” as a 
consequence of anatomic characteristics of women and even 
distinguished different forms of discharge as albus, rufus, ruber, and 
niger. In ancient Babylon and Rome, there is documentation of both male 
and female prostitution. Homosexuality was also present in those days as 
is evident from a number of paintings and pottery. 
In the Holy Bible, there is mention of gonorrhea and syphilis 
showing that these diseases are rampant from ancient times. Before the 
days of microscopy, Gonorrhoea was also mistaken to be syphilis as they 
both produced very similar symptoms and were often silent. These 
diseases were called ‘The great imitators’ by William Osler, an eminent 
physician and they were rampant during the times of World Wars I and 
II. Syphilis and Gonorrhoea were treated with orally ingested mercury 
before antibiotics were discovered leading to many complications.  
‘Malariotherapy’ was considered as a treatment for Syphilis in 
olden days, in which malaria was induced by mosquito bites as a therapy 
in patients suffering from syphilis. 
In India, Vedas are the oldest sacred books and the Atharva Veda 
contained information on venereal diseases, treatment of sexual 
dysfunctions and aphrodisiacs. There has also been clear documentation 
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of female genital infections with herbal cure in an ancient ayurvedic book 
called Bhavaprakasha. The Charaka Samhita has mention of different 
genital diseases, genital discharge and their therapy.  
STD ranks one among the five major problems in developing 
nations according to the WHO. In 1912, the chair of the US committee, 
Prince Morrow looking into the problem of STD said “It is a conservative 
estimate that one-eighth of human suffering comes from this source 
alone”.  
In 1996, WHO global estimates for the four major venereal 
diseases suggested that there were more than 333 million new cases of 
syphilis, gonorrhoea, chlamydia, and trichomoniasis in adults aged 15-49 
years.7 75-85% of them were from the developing countries and the 
highest number of new infections were from South and South-East Asia 
(45.6%), followed by sub-Saharan Africa (19.7%), Latin America and 
Caribbean (10.9%).  
Though adolescents and young adults (15-24 years) make up only 
25% of the sexually active population, they represent around 50% of all 
newly acquired STDs.   
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It is estimated that reported cases of STDs represent only 50%-
80% of reportable STD infections, reflecting on limited screening and 
low disease reporting. Individuals infected with STDs are 5-10 times 
more likely than normal individuals to acquire or transmit HIV through 
sexual contact.  
According to CDC, during 2014–2015 the rate of reported 
gonorrhea increased 18.3% among men and 6.8% among women. In 
2015, a total of 23,872 syphilis cases were reported, and the national 
primary and secondary syphilis rate increased to 7.5 cases per 100,000 
population, a 19% increase from 2014. 
Women are more susceptible to contact STD than men due to 
anatomical, hormonal, physiological and immunological factors. The 
problem is further complicated in women by the social stigma in seeking 
healthcare for STD.8 
STDs in women are divided into ulcerative and non-ulcerative 
types. Abnormal vaginal discharge is the most common among the non-
ulcerative STD.  The prevalence of abnormal vaginal discharge is found 
to be 30% in normal population9 and around 50% in commercial sex 
workers.10  
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A Female Sex Worker by definition is a woman who provides 
sexual favours in exchange for immediate cash or in kind returns. These 
sex workers are the core group and their clients form the bridge group for 
STD transmission to the general population.  
ANATOMY OF THE VAGINA: 
The perineum is a diamond-shaped region bounded by the 
symphysis pubis anteriorly, coccyx posteriorly, and ischial tuberosities 
laterally. The external female genital organs are vulva (labia majora, labia 
minora, clitoris, mons pubis, skene’s glands, bartholin’s glands), vagina 
and urethra. The internal genital organs include cervix, uterus, fallopian 
tubes and the ovaries. Vagina is a fibromuscular tube that is about 9 cm 
long anteriorly and 11.5 cm long posteriorly. It forms a cuff around the 
lower part of cervix and forms 4 fornices, an anterior, posterior and two 
lateral fornices. The vaginal wall has three layers11: 
(1)  The mucous membrane- stratified squamous non keratinized 
epithelium and an underlying lamina propria of connective tissue;  
(2)  The muscular layer- composed of smooth muscle fibers disposed 
both longitudinally and circularly;  
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(3) Adventitial layer- a dense connective tissue that fuses with the 
surrounding fascia. 
NORMAL PHYSIOLOGICAL VAGINAL DISCHARGE: 
There are no sweat, sebaceous or other types of glands in the 
vaginal wall. The fluid production is due to transudation across the 
vaginal wall. Physiological discharge also comprises secretions of the 
endocervix and the Bartholin's gland along with cells that are shed from 
the vaginal walls. These secretions are affected by hormonal changes 
during the menstrual cycle.  The normal vaginal discharge is a 
physiologically important biomass. It is a white or clear discharge that 
varies with the menstrual cycle and does not cause discomfort. The 
physiological discharge is increased during sexual arousal and pregnancy. 
Physiological pH varies in different age groups. At the time of 
birth, vagina of the female baby is colonized by anaerobic and aerobic 
bacteria acquired during passage through the vagina. The epithelium of 
newborn’s vagina is rich in glycogen due to influence of maternal 
estrogens. This results in a low pH (3.7-6.3).  
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Weeks after birth the epithelium becomes atrophic and devoid of 
glycogen, the pH rises to 6-8 (remains so till puberty) and the 
predominant flora are Gram-positive cocci and bacilli. 
At puberty, there is proliferation of vaginal epithelial cells and 
glycogen content in the cells increases due to influence of oestrogen. 
Vaginal cells containing glycogen are shed into the lumen of the vagina. 
As the cells are autolysed, glycogen is converted to glucose, serving as an 
energy source for lactobacilli. Lactobacilli convert glucose to lactic acid, 
which results in a normal vaginal pH of 3.5 to 4.6 (acidic). This is the 
normal vaginal environment, which inhibits the growth of pathogens. 
AGE 
Newborn 
to 
neonate 
Neonate 
to 
puberty 
Puberty to 
menopause 
Pregnancy 
Post 
menopause 
Ph 3.7 - 6.3 6 - 8 3.5 - 4.6 4 - 4.2 6 - 7.5 
 
Lactobacilli also produces hydrogen peroxide, which is bactericidal 
when combined with physiologic amounts of myeloperoxidase and 
chloride. When the normal Lactobacillus-dominated vaginal microbiota is 
lost, the chance of infection on exposure to sexually transmitted 
pathogens increases. The risk for infections in association with pregnancy 
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and gynecologic surgery is also increased when normal vaginal 
microbiota is altered8.  
ABNORMAL VAGINAL DISCHARGE (AVD): 
AVD is defined as any one of the three presentations: 
1)  Excessive vaginal discharge not associated with menstruation  
2)  Offensive or malodourous discharge  
3)  Yellowish mucopurulent discharge 
Abnormal vaginal discharge can be due to infectious or non-
infectious causes. 
CAUSES OF ABNORMAL VAGINAL DISCHARGE: 
INFECTIOUS CAUSES: 
VAGINITIS: 
1. Bacterial Vaginosis  
2. Trichomoniasis  
3. Candidiasis  
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4. Aerobic gram positive bacterial infection (Staphylococcus spp., 
Streptococcus spp., Enterococcus spp.)  
CERVICITIS: 
1. Gonorrhoea  
2. Chlamydiasis 
3. Viral cervicitis due to genital herpes(HSV) or genital warts(HPV) 
4. Syphilis  
5. Tuberculous cervicitis 
NON INFECTIOUS CAUSES: 
1. Gynaecological conditions: (cervical polyp, cervical ectropion, 
Cervical Intraepithelial Neoplasia (CIN), post operative or post 
radiation leucorrhoea, fistulae) 
2. Foreign bodies: (Intra Uterine Contraceptive Devices IUCD, 
retained tampons, retained tissues post partum) 
3. Chemical irritants: (perfumed soaps, antiseptics, douches, 
lubricants, spermicides) 
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4. Hormonal imbalance 
5. Medications: Oral Contraceptive Pills (OCPs), oestrogen creams. 
BACTERIAL VAGINOSIS (BV): 
Bacterial vaginosis is one of the most prevalent causes of 
reproductive tract infections among women of childbearing age. It is also 
known as anaerobic vaginosis. It is a polymicrobial syndrome. BV results 
from the replacement of the normal vaginal flora (Lactobacillus sp. like 
L.crispatus, L. jensenii, L. gasseri, L.iners) with a mixed flora consisting 
of Gardnerella vaginalis, Mobiluncus sp., anaerobes like Prevotella and 
Porphyromonas, Bacteroides ureolyticus, Fusobacterium nucleatum, 
peptostreptococcus and genital mycoplasmas. 
EPIDEMIOLOGY:  
Gardner and Dukes in 1955 described ‘Haemophilus vaginalis 
vaginitis’ as a sexually transmitted disease as the causative agent was 
found in male contacts of the patients as well. BV is considered to be the 
most common etiology of abnormal vaginal discharge throughout the 
world. Incidence is higher with increasing years since marriage, parity of 
greater than two and lower socio-economic status. In rural South India, 
the prevalence among reproductive age group women was found to be 
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20%12. In a study of antenatal women from Chennai, 38% of 
symptomatic women and 16% of asymptomatic women were found to 
have BV.13 
PATHOGENESIS: 
 It is hypothesized that inadequate IgA response against Gvh  
(a hemolytic toxin by Gardnerella vaginalis) increases risk of BV. 
Presence of hydrolytic enzymes like sialidase and protein dipeptidase 
lyse mucin and help in adherence of bacteria. Production of amino acids 
by anaerobes and ammonia by Prevotella is also said to increase 
Gardnerella vaginalis growth. 
Vaginal mucosa and vulva appear normal as the inflammation of 
the vaginal epithelium in the form of leucocytes is seldom seen and so it 
is termed vaginosis instead of vaginitis. 
CLINICAL FEATURES: 
BV manifests as a non-viscous, white, homogenous, malodorous, 
non inflammatory discharge which smoothly coats the vaginal walls 
causing pruritis, pain during coitus and lower abdominal pain. Patients 
may complain of foul odour immediately after intercourse due to 
17 
 
alkalination of vaginal secretion by semen producing volatile 
polyamines.14 
DIAGNOSIS: 
Self-diagnosis of bacterial vaginitis is usually not correct. In a 
study of 552 women aged 16 years or older, only 3–4% of women could 
accurately identify the symptoms associated with BV. So the diagnosis is 
to be made based on clinical and laboratory methods. 
AMSEL’S CRITERIA: 
           Amsel’s criteria for Bacterial Vaginosis is based on clinical 
findings and has four criteria. When at least three out of these four 
criteria are fulfilled, it is suggestive of Bacterial Vaginosis: 
1. A thin homogeneous, white, uniformly adherent vaginal discharge 
without granular material;  
2. Elevation of the pH of vaginal fluid above 4.5; This has the highest 
sensitivity but least specificity. 
3. Development of a dead-fish odor after mixing vaginal fluid with 
10% KOH;  
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4. “Clue cells” on microscopic examination of vaginal fluid. Clue 
cells are epithelial cells heavily coated with bacteria sufficient to 
obscure the cell borders. Detection of clue cells is the single most 
useful procedure for diagnosis of BV. 15 
Vaginal pH has the greatest sensitivity of the four criteria but 
lowest specificity.14 Detection of ‘Clue cells’ is the single most useful and 
specific criterion to diagnose BV and when other three clinical criteria 
are fulfilled in absence of ‘clue cells’ the diagnosis of BV based on 
Amsel’s criteria becomes questionable. 
Gram stain of normal vaginal fluid shows a predominance of 
lactobacilli with normal epithelial cells, whereas the Gram stain of 
vaginal fluid from a woman with BV shows a decrease or absence of 
lactobacilli and a predominance of Gram-variable cocco-bacilli.  
Nugent’s criteria uses gram stained smears of vaginal discharge to 
diagnose Bacterial Vaginosis. Various morphotypes are identified and 
graded according to Nugent’s scoring system. Lactobacilli type (large 
gram-positive rod), Gardnerella type (small gram-negative or gram 
variable rod) and Mobiluncus type (Curved negative/variable rod) are the 
morphotypes included.  
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A score of 0-3 is normal vaginal flora, 4-6 is considered 
intermediate and 7 to 10 is reported as Bacterial Vaginosis. Intermediate 
flora also needs to be intimated to the clinician as in 32% of cases, 
intermediate flora progresses to Bacterial Vaginosis.  
NUGENT’S CRITERIA: 
BACTERIAL 
MORPHOLOGICAL TYPE 
SCORE 
NONE 1+ 2+ 3+ 4+ 
LACTOBACILLI TYPE(Large 
Gram-positive rod) 
4 3 2 1 0 
GARDNERELLA TYPE(Small 
Gram-negative/variable rod) 
0 1 2 3 4 
MOBILUNCUS TYPE (Curved 
negative/variable rod) 
0 1 2 3 4 
 
SCORE KEY: 
<1/oil immersion field 1+ 
1-5/ oil immersion field 2+ 
6-30/ oil immersion field 3+ 
>30/ oil immersion field 4+ 
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INTERPRETATION OF NUGENTS’S SCORE: 
NUGENTS’S SCORE INTERPRETATION 
0-3 NORMAL 
4-6 INTERMEDIATE-to be repeated later 
7-10 BACTERIAL VAGINOSIS 
 
Nugent’s Scoring has sensitivity of 86-89% and specificity of 94-
96% when compared to Amsel’s criteria.  
HAYS/ISON SCORING is based on gram staining to estimate 
ratio of observed monotypes rather than exact number of bacteria. This 
has 5 categories:  
Group 0 : no bacteria at all 
Group 1 : normal 
Group 2 : intermediate 
Group 3 : Bacterial Vaginosis 
Group 4 : numerous gram positive cocci present 
SCHMIDT’S SCORING of wet mount preparations is validated 
for diagnosis of BV at primary health care level. It is similar to Nugent’s 
scoring but uses wet mount preparation instead. 
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Though clinical methods like Amsel’s criteria are useful for 
bedside diagnosis and treatment, Gram-stained smear grading method 
appears to be more accurate. 
SEROLOGIC METHODS: 
Gas liquid chromatographic identification of fatty acids showing 
ratio of succinate to lactate peaks of more than 0.4 is highly suggestive of 
Bacterial vaginosis. Rapid nucleic acid hybridization test, proline 
aminopeptidase activity, amine test are other tests used. But the 
sensitivity of serologic tests in diagnosis of BV is poor. 
TREATMENT: 
National AIDS Control Organisation NACO (2004) regimen - T. 
Metronidazole 400 mg orally twice daily for 7 days or 2 gm orally single 
dose or T. Tinidazole 2 gm orally as a single dose. 
TRICHOMONIASIS: 
Trichomonas vaginalis is a pathogenic protozoan parasite of the 
human urogenital tract. It is transmitted by sexual route and causes 
vaginitis in women and urethritis in men. A proportion of infections are 
also asymptomatic. According to the World Health Organization (WHO) 
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trichomoniasis causes more than half of all curable sexually transmitted 
infections (STI) worldwide16. 
HISTORY:  
T. vaginalis was first described in 1836 by French physician Alfred 
Donné. He observed the organisms in a preparation of fresh vaginal 
discharge and regarded it to be a commensal of vaginal tract. But in the 
1940s, T. vaginalis was established as an etiologic agent of vaginitis as it 
fulfilled the Koch’s postulates. 
EPIDEMIOLOGY:  
In general, T. vaginalis is highly prevalent among sexually active 
women. Among women presenting with vaginal complaints, the reported 
prevalence of trichomoniasis can be as high as 75%17. However, 
approximately 50% of infections with T. vaginalis may be subclinical in 
presentation18.  
T. vaginalis is transmitted almost exclusively by sexual 
intercourse. Although nonsexual transmission by contaminated fomites 
may explain reports of trichomoniasis in a few patients, such as sexually 
mature virgins, the data suggest that non-sexual transmission of T. 
vaginalis is rare.  
23 
 
Three species are found in humans- Trichomonas vaginalis is a 
parasite of the genitourinary tract, T. tenax is found in the oral cavity, 
Pentatrichomonas hominis is seen in large intestine. Trichomonads exist 
only in the motile, vegetative trophozoite form, and true cysts stages have 
not been described. They are primitive eukaryotes and cannot synthesize 
macromolecules de novo. 
PATHOGENESIS: 
Trichomonas vaginalis produces many proteolytic enzymes 
involved in cytotoxicity and haemolysis. Both contact dependent and 
independent mechanisms are seen. It has adhesion proteins AP 23, 33 and 
65 using which it attaches to epithelial cells. They attach not only to 
epithelial cells but also to extracellular matrix substances like fibronectin 
and laminin. 
The Cell detaching factor (CDF) which has trypsin like activity 
also acts as a virulence factor. Some women become symptomatic after 
menstruation, suggesting a role for iron in the pathogenesis of 
trichomoniasis19. Trichomonas evades immune response by molecular 
mimicry, its ability to coat itself with host proteins and complement 
mediated destruction. 
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CLINICAL PICTURE: 
The spectrum varies from asymptomatic disease to severe vaginal 
infection. However, vaginal discharge can be seen in more than 50% of 
patients. Vaginitis is the most common presentation followed by infection 
of the urethra, Bartholin’s gland, Skene’s gland and endocervix.  
Trichomoniasis is characterized by malodorous greenish-yellow 
frothy discharge with intense itching. Dyspareunia, burning micturition 
and abdominal pain may be present. Colpitis macularis also called 
‘Strawberry cervix’ is due to microscopic punctate hemorrhages over the 
cervix. T. vaginalis is associated with Bacterial vaginosis- like vaginal 
flora showing reduced lactobacilli and colonization with Gardnerella 
vaginalis20.  
DIAGNOSIS: 
Direct microscopic examination of wet mount preparation: 
Diagnosis by wet mount is by observing viable active trophozoites 
with characteristic twitching type of motility. Trichomonads are around 
15 µm in size, pyriform in shape with anterior tuft of flagella and a lateral 
undulating membrane.  Wet mount microscopy is about 50–70% sensitive 
in women with trichomoniasis 21. But since the parasite loses viability in 
normal saline if left more than 20 minutes at room temperature22, Wet 
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mount examination is to be done as early as possible. Samples should not 
be centrifuged before processing as the fragile flagella are detached 
during centrifugation. The parasite can be stained by various staining 
methods like Gram stain, Giemsa stain, periodic acid-Schiff, 
Papanicolaou , acridine orange, fluorescein, and immunoperoxidase 
staining.    
CULTURE: 
Culture remains the gold standard for diagnosing trichomoniasis 
among women23.  It is more sensitive than the wet mount examination as 
it can detect as low as 300-500 trophozoites/ml. But the time duration 
required is a minimum of 2 days to a maximum of 7 days. The culture 
media used are either semi-solid or liquid media. The most commonly 
used media are Diamond’s media, Modified Diamond’s media, CPLM 
(Cysteine Peptone Liver Maltose) media, modified CPLM media, In-
pouch Trichomonas media, Kupferberg media, Feinberg Whittington 
media etc. A combined approach of wet mount examination followed by 
culture if microscopy is negative is very useful24. 
CELL CULTURE: 
It is superior to both wet mount microscopy and regular culture 
methods as it can pick up trophozoites as low as 3/ml.  
26 
 
RAPID DIAGNOSTIC TESTS: 
Oligonucleotide probe tests, immuno-chromatographic assays that 
detect trichomonas antigens in vaginal swabs and PCR assays have been 
developed. Rapid tests may be useful in settings where culture and 
microscopy are not available. 
TREATMENT:  
NACO (2004) regimen Metronidazole 500 mg orally twice daily 
for 7 days or 2 gm orally single dose/ Tinidazole 2 gm orally as a single 
dose. 
CANDIDIASIS: 
Candidiasis is the most common fungal disease in humans 
affecting skin, mucosa, nails and internal organs. It is also called 
Moniliasis.  It is caused by a group of yeasts belonging to genus Candida 
with prototype species Candida albicans. Several non-albicans Candida 
species have been described and their incidence has been on the rise in 
recent days. 
Women having Vulvo Vaginal Candidiasis (VVC) present with a 
spectrum of manifestations ranging from asymptomatic colonisation to 
severe acute symptomatic infection. Certain patients may develop mainly 
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vulvar symptoms like soddening of skin and vulvar pruritis instead of 
vaginal manifestations. 
Candida species causing Vulvo-Vaginal Candidiasis: 
¾ Candida albicans 
¾ Candida tropicalis 
¾ Candida krusei 
¾ Candida glabrata 
¾ Candida haemulonii 
¾ Candida guilliermondii 
¾ Candida parapsilosis 
¾ Candida lusitaniae 
¾ Candida kefyr (formerly C. paratropicalis) 
¾ Candida dubliniensis 
Around 85% of candidal strains cultured from the vagina are 
Candida albicans.25 The rest are non-albicans, the commonest of which is 
C. glabrata. Non-albicans vaginitis is not clinically distinguishable from 
vaginitis caused by C. albicans but it is more resistant to therapy. The use 
of single dose oral anti-fungal regimens and over-the-counter anti-
mycotics, are responsible for this increase. 
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PATHOGENESIS: 
Candida colonize the vaginal epithelium after adhering to it. The 
yeast adhesin is seen in surface manno-protein. Germination of yeast 
cells increases colonization and invasion of tissue. Ibrahim et al., have 
strongly implicated phospholipases as a virulence factor in the 
pathogenesis of C. albicans.26 Candida usually gain access to vagina from 
the adjacent perianal region.  
RISK FACTORS: 
Host factors include immunodeficiency (HIV), pregnancy, 
immunosuppressive drugs, chemotherapy, uncontrolled Diabetes, 
corticosteroids therapy, Oral Contraceptive Pills (OCP), broad spectrum 
antibiotic therapy, Hormone Replacement Therapy (HRT), oro-genital 
sex practices etc. 
Progesterone is shown to have suppressive effect on anti-Candida 
action of neutrophils and estrogen reducing the ability of vaginal 
epithelial cells to inhibit candida colonization. This could explain the 
higher incidence of Candidiasis in pregnancy, OCP usage and HRT. 
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CLINICAL PICTURE: 
Vaginal discharge is characteristically curdy, cottage cheese like in 
appearance but can vary from watery to homogenous thick discharge. 
However, vaginal discharge is not always present and is mostly minimal. 
Vaginal soreness, burning, dysuria, dyspareunia are major complaints and 
symptoms are more in the week preceding menstruation.  
On examination vulvar erythema and pustulo-papular lesions may 
be seen. VVC is divided into uncomplicated and complicated disease 
based on host or microbial factors and these factors have a profound 
impact on outcome of therapy.  
FACTORS UNCOMPLICATED VC COMPLICATED VVC 
Frequency <4 episodes per year  4 episodes per year 
Severity Mild to moderate Moderate to severe 
Microscopy Pseudophypae /hyphae seen Budding yeast only 
Host Healthy 
Pregnant females, diabetes, 
immune compromised 
patients. 
 
DIAGNOSIS: 
Direct microscopy: 
Wet mount microscopy of vaginal discharge with a drop of normal 
saline shows budding yeast cells with pseudohyphae.  
30 
 
This is better identified by a 10% potassium hydroxide (KOH) 
preparation which is more sensitive in identifying germinated yeast cells 
(sensitivity of 65–85%). KOH is a strong alkali helping in clearance of 
epithelial cells and digestion of keratin material, thus the fungal elements 
can be clearly seen. This clearing can be hastened by slightly heating the 
KOH mount over a flame. 
Vaginal pH in VVC is almost normal (4.0–4.5) and if pH is in 
excess of 5.0 usually it is BV, trichomoniasis, or a mixed infection. 
Culture methods: 
Culture of vaginal discharge is the most sensitive and specific 
method for detecting Candida, but a positive culture alone cannot confirm 
VVC since 10–15% of normal asymptomatic women are colonized with 
Candida and are invariably culture positive. Positive culture results are to 
be correlated with direct microscopy showing high number of yeast cells 
and polymorphonuclear cells to confirm VVC. 
There is no reliable serologic method or antigen-detection 
technique for diagnosing VVC. 
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SPECIATION OF CANDIDA: 
Cultures positive for yeast cells can be differentiated into  
C. albicans and non albicans Candida (NAC) by the Germ Tube Test also 
called as Reynolds-Braude phenomenon. C. albicans and C. dubliniensis 
alone form germ tubes within 2 hours of incubation in serum. A germ 
tube is a lateral hyphal extension from the yeast cell without any 
constriction at the base. 
CHROMagar is a newer culture medium that distinguishes 
different species of Candida by a characteristic colour for each species.51 
This is based on detection of specific enzymatic activities by addition of 
substrates of fluorochromes to the media.27  
Candida species Colour on CHROMagar 
Candida albicans Light green to bluish green 
Candida tropicalis Dark blue 
Candida glabrata Pink to purple 
Candida parapsilosis Cream coloured 
Candida dubliniensis Dark green 
Candida krusei Pinkish to purplish 
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Triphenyl Tetrazolium Chloride (TTZ) is another chromogenic 
medium that differentiates Candida species based on the colour produced. 
Culture of suspected Candida strains are inoculated in Corn Meal 
Agar or Rice Starch Agar by Dalmau technique for 48-72 hours to show 
production of chlamydospores in C.albicans and C. dubliniensis. The 
tween present in corn meal agar and the sub surface inoculums provides a 
low surface tension favouring development of hyphal and pseudohyphal 
forms, chlamydoconidia and blastoconidia.  
Candida species Morphology on Corn meal Agar 
Candida albicans Terminal chlamydospores 
Candida tropicalis Branching pseudohyphae and blastoconidia 
Candida glabrata No pseudohyphae, only blastoconidia 
Candida parapsilosis Curved pseudohyphae and blastoconidia 
Candida dubliniensis Terminal chlamydospores 
Candida krusei 
Pseudohyphae and blastoconidia resembling 
crossed match sticks 
 
Of late, tobacco agar and casein agar are reported to selectively 
induce chlamydospore formation in C. dubliniensis differentiating it from 
C. albicans. Other species of Candida can be differentiated based on 
pseudohyphae, arthrospores and blastospores formation. 
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Carbohydrate assimilation tests are also used to speciate Candida 
isolates based on the sugars utilised. 
ANTI-FUNGAL SUSCEPTIBILITY TESTING: (AFST) 
Disc Diffusion Test: MHA with 2% glucose and GMB (Gomorri 
Methylene Blue) medium 
According to the CLSI M44-A2, Mueller Hinton Agar (MHA) is 
considered to a good choice for AFST procedure. When supplemented 
with glucose to a concentration of 2%, it provides for fungal growth. The 
addition of Methylene Blue Dye (GMB) to a concentration of 0.5 µg/ml 
enhances the zone edge definition.28 The pH is adjusted between  
7.2 and 7.4  
Inoculum is standardised to 0.5 McFarland standard and after 
placing anti-fungal discs plates are incubated at 35ňC for 24 hours. 
Interpretive zone diameter: 
Drug tested RESISTANT S-DD(Susceptible Dose Dependant) SENSITIVE 
Fluconazole 25 µg 14 15-18 19 
Itraconazole10 µg 13 14-22 23 
Voriconazole 1 µg 13 14-16 17 
Amphotericin B 20 µg 10 10-14 15 
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Candida krusei shows intrinsic resistance to Fluconazole and 
should not be interpreted with this scale for Fluconazole. Other non 
albicans Candida also show varying degrees of azole resistance. This 
highlights the importance of routine speciation and anti-fungal 
susceptibility testing for all Candida cultures. 
Minimum Inhibitory Concentration by Microbroth dilution:  
According to M27-A329, MIC testing is done using Rosewell Park 
Memorial Institute medium (RPMI-1640 medium) with glutamine 
without bicarbonate. It is supplemented with 0.2% glucose and buffered 
to the pH of 7.0. Inoculum is standardised to 0.5 McFarland standard 
added to RPMI medium in a microtitre plate. To this, liquid preparation 
of drugs in the concentration to be tested are added in doubling dilution. 
The plate is incubated at 35ňC for 24 hours and interpretation done using a 
reading mirror.  
The MIC for azoles is the lowest concentration with an optical 
score of 2. (prominent decrease in turbidity). MIC for Amphotericin B is 
the lowest concentration with score of 0 (optically clear).  
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TREATMENT: 
Fluconazole 150 mg single dose therapy is indicated in 
uncomplicated VVC and intensive regimen is recommended for 
complicated VVC with longer duration of treatment and higher dosage of 
drugs. 
AEROBIC VAGINITIS: 
In 2002, Donder suggested the term Aerobic Vaginitis(AV) and 
described it as being caused by enteric commensal flora like 
Streptococcus agalactiae, Escherichia coli, Enterococcus spp., 
Staphylococcus spp. AV was determined based on Donder’s criteria: 
¾ Enhanced yellowish vaginal discharge 
¾ pH value >/= 5 
¾ Increased number of leucocytes >10 
¾ Negative whiff test 
¾ Absence of lactobacilli 
¾ Most commonly isolated organisms- Staphylococcus aureus, 
Escherichia coli, Enterococcus, Group B Streptococcus etc. 
36 
 
Modified Donder’s grading of gram stained smears for diagnosis of 
Aerobic Vaginitis: 
Score 
Lacto 
bacillary 
grade 
No. Of 
leucocytes 
Proportion 
of toxic 
leucocytes 
Background 
flora 
Proportion 
of 
parabasal 
cells 
0 I, IIA </=10/ HPF 
None or 
sporadic 
Unremarkable none 
1 II B 
>10/HPF or 
</=10 /EPI 
CELL 
</= 50% of 
leucocytes 
Small 
coliforms 
</= 10% 
2 III >10 /EPI CELL 
>50% of 
leucocytes 
Cocci in 
chains 
>10% 
 
SCORING: 
<3 : Normal 
3-4 :  Slight aerobic vaginosis 
5-6 :  Moderate aerobic vaginosis 
6-10 :  Severe aerobic vaginosis 
CERVICITIS: 
Cervicitis is the inflammation of the cervical epithelium. It can be 
gonococcal cervicitis or non-gonococcal cervicitis.  
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GONOCOCCAL CERVICITIS: 
Gonorrhoea is derived from – ‘gonos’ meaning ‘seed’ and ‘rhoea’ 
meaning ‘flow’. It was thought that syphilis and gonorrhoea were caused 
by same organism until Neisseria gonorrhoea was identified as the 
causative organism of gonorrhoea in 1879 by Albert Neisser.  
Nowadays gonorrhoea commonly referred to as ‘the Clap’ or ‘the 
Drip’ is presently the second most commonly reported notifiable disease 
in the US. The WHO estimates worldwide, 78 million people get 
gonorrhoea each year with majority of cases affecting the young under 
the age of 25. 
In women, the endocervical canal is the most common site of 
gonococcal infection but only 50% of infected women have symptoms. 
Urethral colonization is also seen in 70–90% of infected women, but is 
not common in the absence of cervicitis. Infection of the skene’s and 
bartholin glands is also seen. In most patients, there is mucopurulent 
cervical discharge, edema and erythema of cervix and mucosal bleeding 
on swabbing the endocervix.  
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PATHOGENESIS:  
Primary infection occurs in columnar epithelium of urethra, cervix, 
conjunctiva etc. Penetration of cocci occurs through intercellular spaces 
and reaches the sub- epithelial tissue by third day followed by adherence, 
invasion and tissue damage due to lipo-oligosaccharides and 
peptidoglycans. In pre-pubertal girls, rarely primary infection may also 
occur in stratified squamous epithelium of vagina. 
CLINICAL FEATURES: 
The common symptoms in females are burning micturition, 
mucopurulant cervical discharge, erythema and edema of cervix which 
may bleed on touch. The rectal mucosa may be infected in 35-50% of 
women. Pharyngeal infection as a result of oro-genital sex can also occur. 
DIAGNOSIS: 
Microscopy: 
Direct gram staining of endocervical secretion reveals numerous 
polymorphonuclear cells in gram negative intracellular diplococci. The 
diplococci are characteristically kidney bean shaped and around 0.8 µm × 
0.6 µm in size. The specificity of gram stain is 95-97% in male urethral 
discharge but only 40-60% in endocervical discharge.30  
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CULTURE:  
Culture is the most specific investigation and done on Modified 
Thayer Martin medium (MTM), New York City (NYC) medium, Chacko 
Nayar medium and Martin Lewis medium under 5-10% CO2 incubation. 
MTM is incorporated with VCN supplement. (Vancomycin to 
inhibit gram positive bacteria, Colistin to inhibit gram negative bacteria 
and nystatin to inhibit fungal growth). Culture yields Neisseria 
gonorrhoea with a diagnostic sensitivity of 80–95% for promptly 
incubated samples.30   
Confirmatory Test for Neisseria gonorrhoea: 
RAPID CARBOHYDRATE UTILISATION TEST: (RCUT) 
This is a reliable method to distinguish Neisseria gonorrhoea from 
other Neisseria spp. It is a non growth dependent method and tests both 
carbohydrate utilisation and beta-lactamase production. Carbohydrates 
routinely tested include glucose, maltose, sucrose and lactose. 
Neisseria gonorrhoea utilizes only glucose and hence shows a color 
change for glucose alone. 
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Non culture methods like Nucleic acid amplification tests 
(NAATs) for diagnosing gonorrhoea are also available now. 
COMPLICATIONS: 
Salpingitis leading to PID, bartholin gland abscess, disseminated 
gonococcal infection, Gonococcal arthritis, meningitis, endocarditis, 
ophthalmia neonatorum are all complications of gonorrhoea. 
TREATMENT: 
The currently recommended therapy for uncomplicated gonorrhea 
by the CDC is a single i.m injection of ceftriaxone 125 mg or Cefixime 
400 mg orally single dose along with a single 1-g oral dose of 
azithromycin. 
Gonorrhoea was initially treated with sulphonamides and when 
resistance developed, Penicillin became the drug of choice. Within 10-15 
years, penicillin resistance by Penicillinase producing Neisseria 
gonorrhoea (PPNG) had spread to a great extent and fluoroquinolones 
were the treatment widely used.31 Since the spread of fluoroquinolone 
resistance in 2010, the cephalosporin antibiotics have been the foundation 
of treatment. The emergence of extended spectrum cephalosporin-
41 
 
resistant ‘SUPERBUG’ gonococcus is highly detrimental, since there are 
very few antibiotic options left to treat these gonorrhoeas.  
As of July 2017, there are three cases of totally untreatable 
gonorrhoea cases identified in which all known antibiotics were found to 
be resistant. This was caused by newly discovered H041 strain of 
Neisseria gonorrhoea. One of the cases was in France, one in Japan and 
one in Spain. This is an imminent threat to the community as there will 
be no antibiotic left to treat Gonorrhoea if this superbug spreads around 
the world. 
DIFFERENTIAL DIAGNOSIS OF ABNORMAL VAGINAL 
DISCHARGE: 
Diagnostic 
 criteria 
Normal 
Bacterial 
Vaginosis 
Trichomonas 
vaginitis 
Vulvovaginal 
candidiasis 
Discharge 
 
 
White, thin, 
flocculent 
 
Thin, white 
homogenous,  
grey 
Yellow, green, 
frothy 
 
White, curdy, 
"cottage 
cheese" 
Vaginal pH 3.8 - 4.2 > 4.5 4.5 < 4.5 (usually) 
Microscopic 
Lactobacilli,  
epithelial  
cells 
Clue cells,   
no WBC's 
Trichomonads, 
WBC's >10/ 
hpf 
Budding yeast, 
hyphae, 
pseudohyphae 
Amine odor 
"whiff" test 
Absent Fishy Fishy Absent 
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SYNDROMIC MANAGEMENT (NACO): 
As per NACO guidelines in 2007 any patient presenting with 
abnormal vaginal discharge is categorized into VAGINAL DISCHARGE 
SYNDROME and a pre-determined single dose drug combination is 
administered to collectively treat all probable causes of vaginal discharge. 
This is labeled the GREEN KIT and consists of 2 drugs:  
¾ T. Secnidazole 2gm orally, single dose to treat BV and TV; 
¾ T. Fluconazole 150 mg orally, single dose to treat Candidiasis.11 
 
 
 
 
 
 
 
MATERIALS  
AND  
METHODS 
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MATERIALS & METHODS 
STUDY PLACE: 
1.  Department of Microbiology, Government Stanley Medical 
College, Chennai. 
2.  Department of Obstetrics & Gynaecology, Govt. RSRM Lying-in 
Hospital, Chennai. 
3.  Department of Sexually Transmitted Diseases, Govt. Stanley 
Medical College, Chennai. 
STUDY DESIGN:  
Prospective study. 
SAMPLE SIZE :  200 IN NUMBER.    
STUDY PERIOD : 
October 2016 to September 2017 
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INCLUSION CRITERIA: 
1.  Women of reproductive age group (18-45) belonging to normal 
population who present with abnormal vaginal discharge to the 
Gynaecology OPD in Govt. RSRM lying-in Hospital 
2.   Women of reproductive age group (18-45) belonging to high risk 
groups who present with abnormal vaginal discharge to the STD 
OPD in Govt. Stanley Medical College Hospital.  
HIGH RISK GROUP  
includes-    Female Sex Workers 
                                 Females having multiple sexual partners 
                                           Females with high risk partners 
                                           Females with known venereal diseases 
3.  Women of reproductive age group who presented with other 
complaints like lower abdominal pain, infertility or irregular 
menstruation but had abnormal vaginal discharge on examination.  
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EXCLUSION CRITERIA: 
1.  Women who are not willing for examination 
2.  Pregnant women 
3.  Post-menopausal women 
4.  Women below the age of 18 and over the age of 45 
5.  Women on antibiotic course 
6.  Women on their menstrual period 
STATISTICAL ANALYSIS : 
 Statistical Analysis was done using IBM-SPSS Statistics – 20 
statistical package. Variables were analysed using student ‘t’ test, Chi 
square test and Z test of proportions wherever necessary. The P value less 
than 0.05 (P<0.05) were treated as significant in two tail test.  
ETHICAL CONSIDERATION: 
This study has been approved by the Institutional Ethic Committee 
of Govt. Stanley Medical College and informed consent was obtained 
from the patient before inclusion in the study. 
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MATERIALS: 
Sample Source: Cervico-Vaginal discharge  
Materials Required: Sterile dacron swabs, sterile glass test tubes, 
clean glass slides, pH indicator strips( narrow range 3.5 to 6), chemicals 
and reagents like normal saline,10%  Potassium hydroxide. 
Media Required: 
5% Sheep Blood agar  
Modified Thayer Martin Medium 
Cysteine Peptone Liver Maltose (CPLM) 
Sabouraud’s Dextrose Agar 
CHROMagar for Candida 
Corn Meal Agar 
Gram staining reagents 
Giemsa staining reagents 
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METHODS:  
This study has been approved by the Institutional Ethic Committee 
of Govt. Stanley Medical College. 
After informed consent from the patient is obtained, the patient 
details are collected and presenting complaints are noted.  
The details about  quantity of vaginal discharge, mode of onset, 
relation to menstrual cycle, duration, presence of itching/irritation 
(localized or generalized, provoked, intermittent, or chronic), colour, 
consistency, odour of discharge, associated abdominal pain, dysuria  and 
dyspareunia are elicited.  
The medical history elicited includes all of the usual gynecologic 
parameters, including menstrual history, pregnancies, contraception, 
sexual preference, past and current sexual relationships, vaginal hygiene 
practices (douching) and prior genitourinary infections. The patient is 
also asked about underlying medical conditions such as allergies, 
diabetes, malignancies, and immunodeficiency syndromes.  
General examination of the patient is done and relevant systemic 
examination is done. The patient is then made to lie comfortably in 
supine position on an examining table in a covered cubicle.  
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Inspection of external genitalia is done; the pubic hair is examined 
for the presence of pthirus pubis or nits. The inguino-femoral area is 
palpated for adenopathy. Suprapubic and lower abdominal tenderness or 
masses are sought by palpation.  
The patient is then asked to lie in lithotomy position and the 
external genitalia should be carefully inspected. The patient is asked to 
point to any areas of external itching, irritation, or other discomfort. The 
appearance of the vulval skin and vestibular mucous membranes is noted, 
with careful attention to ulcers or other discontinuity of the skin or 
mucosa, mucosal erythema, labial edema and visible secretions.  
By spreading the labia with the gloved hand, the urethral meatus is 
examined for any discharge. The introitus and the internal surfaces of the 
labia minora are examined for lesions. 
Under speculum examination, the vaginal mucosa and cervix are 
inspected for any erosion or ectropion and nature of vaginal discharge is 
noted.  
Two high vaginal swabs are taken from the lateral fornices and one 
endo-cervical swab is taken under strict aseptic precautions. Finally, 
bimanual examination for adnexal tenderness and masses is done. 
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One high vaginal swab is used to inoculate 5% Sheep Blood Agar 
Plate (BAP), Sabouraud’s Dextrose Agar (SDA) and Cysteine Peptone 
Liver Maltose (CPLM) medium. These are incubated at 37ňC.  
The  2nd high  vaginal  swab  is  used  to  make  a  wet  mount  with  
normal saline, a wet mount with 10% KOH, a smear for gram staining 
and the vaginal pH is tested using a pH indicator strip of range 3.5 to 6.0. 
The cervical mucus is avoided since it has a higher pH (pH 7.0) than the 
vaginal fluid.   
The sample is then examined for odor (whiff test) by placing a 
drop on a microscope slide, adding a drop of 10% potassium hydroxide 
(KOH), and smelling the resultant mixture. Normal secretions have no 
odour and a fishy odor is indicative of BV. The Amsel’s criteria is thus 
applied to diagnose BV. 
The endo-cervical swab is first inoculated onto Modified Thayer 
Martin medium (MTM) and incubated at 370C in 5-10% CO2 atmosphere 
by placing the streaked plates in a candle jar with a piece of moist cotton 
to provide moisture.  
The swab is then used to make a smear for gram staining by gently 
rolling the swab in one direction onto a grease-free clean glass slide.  
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This uni-directional smearing technique helps to minimize 
distortion and breakage of polymorphonuclear leukocytes (PMNL) thus 
preserving the characteristic intracellular appearance of gonococci.  
For Gram staining the smears were fixed with alcohol, flooded 
with methyl violet for one minute and washed in running tap-water and 
then flooded with Gram’s iodine for one minute. The films were then 
decolourized with acetone, washed immediately with water and counter-
stained with dilute carbol fuschin for one minute. The films were then 
washed with water and allowed to air dry. 
OBSERVATION: 
The wet mount is examined under high power with a bright-field 
microscope for presence of epithelial cells, clue cells, polymorphonuclear 
neutrophils (PMNs) and budding yeast cells with pseudo-hyphae. The 
relative numbers of epithelial cells and PMNs is noted. 
The wet preparation is also scanned for trophozoites of 
Trichomonas vaginalis which are identified by their characteristic 
twitching motility. 
The KOH mount is examined for budding yeast cells with or 
without pseudo-hyphae.  
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The gram-stained high vaginal smear is examined for presence of 
epithelial cells, clue cells, gram positive lactobacilli, gram variable 
cocco-bacilli, PMNs, budding yeast cells with pseudohyphae and is also 
scored according to Nugent’s score for Bacterial Vaginosis. 
The gram stained endocervical smear is examined for PMNs and 
intracellular gram negative diplococci which suggest gonorrheal 
cervicitis. 
Presence of >30 PMN/ high power field with no gram negative 
diplococci is an indirect clue for the diagnosis of Chlamydial Cervicitis. 
The BAP incubated at 370C is examined after 24 hours and any 
colony grown is identified by gram staining and biochemical reactions.   
The SDA tube is examined for creamy-white colonies suggestive 
of Candida and gram stain is done. Any budding yeast cells isolated are 
subjected to germ tube test (Reynauld’s braude phenomenon) and 
streaked on CHROMagar and Corn meal agar to speciate Candida. 
The MTM incubated in candle jar is examined after 24-48 hours 
for tiny translucent water-drop like colonies.  
 
52 
 
Gram stain and oxidase test is done and if gram negative 
diplococci which are oxidase positive is seen, further confirmation is 
done using RCUT (Rapid Carbohydrate Utilisation Test) to confirm 
Neisseria gonorrhea.  
The CPLM medium is examined for motile trophozoites of 
trichomonas by wet mount examination every alternate day for 7 days 
before it can be declared negative. The motile trophozoites found are 
fixed in smear and stained by Giemsa stain to study the morphology. 
 
 
 
 
 
 
 
 
 
RESULTS 
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RESULTS 
The total number of patients included in the study was 200 in 
which 147 patients belonged to general population from Gynaecology 
OPD and 53 patients belonged to High Risk Groups from STD OPD. 
TABLE 1: DISTRIBUTION BASED ON RISK FACTORS: 
STUDY 
POPULATION 
NO. OF 
PATIENTS 
PERCENTAGE 
GENERAL 
POPULATION 
147 73.5% 
HIGH RISK GROUPS 53 26.5% 
TOTAL 200 100% 
  
 
 
73%
27%
CHART 1: STUDY POPULATION
GENERAL
POPULATION(n=147))
HIGH RISK(n=53)
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Based on the presenting complaints the patients are classified into: 
¾ Those who presented with abnormal vaginal discharge as the chief 
presenting complaint  and 
¾ Those who presented with other complaints like lower abdominal 
pain, infertility, dysuria etc. and were found to have abnormal 
vaginal discharge on examination. 
TABLE 2:  
DISTRIBUTION BASED ON PRESENTING COMPLAINTS 
Chief presenting complaint 
General 
population 
High-risk 
groups 
Total 
Abnormal vaginal discharge 102(69%) 44(83%) 146(73%) 
Infertility/ lower abdominal 
pain/ Irregular menstruation 
45(31%) 9(17%) 54(27%) 
Total 147 53 200 
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TABLE 3: DISTRIBUTION BASED ON AGE 
AGE (YRS) 
GENERAL 
POPULATION 
HIGH RISK 
GROUP 
18-29 58(39.5%) 18(33%) 
30-39 61(41.5%) 25(47%) 
40-45 28(19%) 10(20%) 
TOTAL 147 53 
Mean ±SD 31.6 ±7.2 32.2 ±6.9 
Significance 
t-value=1.62 
degree of freedom=198 
p value = 0.0534 
p value > 0.05 
 
The study included menstruating women of reproductive age group 
from 18 years to 45 years.  The most common age group in both the 
groups was 30-39 years. Mean age among general population was 31.6 
±7.2 and among high risk groups was 32.2 ±6.9. Since the p-value was 
>0.05, the two groups were similar in terms of distribution of age and 
thus a comparison can be made between them. 
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CHART 2: AGE-WISE DISTRIBUTION 
 
TABLE 4: DISTRIBUTION BASED ON MARITAL STATUS 
MARITAL 
STATUS 
GENERAL 
POPULATION 
HIGH RISK 
GROUP 
Unmarried 0 5(9.4%) 
Married 136(92.5%) 24(45.2%) 
Widowed 3(2.0%) 7(13.2%) 
Separated 8(5.4%) 17(32.2%) 
Total 147 53 
Significance 
஗2 = 50.032 
P value <0.00001 
P<0.05 
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There is a significant difference between general population and 
high risk group based on their marital status (p<0.05). The percentage of 
separated and divorced women in high risk groups was significantly more 
than general population. 
CHART 3: DISTRIBUTION BASED ON MARITAL STATUS
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TABLE 5: DISTRIBUTION BASED ON EDUCATION 
EDUCATION 
GENERAL 
POPULATION 
HIGH RISK 
GROUP 
Illiterate 6(4.1%) 5(9.4%) 
Primary school 23(15.7%) 13(24.6%) 
Middle school 19(12.9%) 17(32.1%) 
High school 46(31.3%) 11(20.8%) 
Higher secondary 32(21.7%) 6(11.3%) 
Degree 21(14.3%) 1(1.8%) 
Total 147 53 
Significance 
஗2 =4.25 
Degree of freedom=5 
P value = 0.514 
p>0.05 
 
Most common education level in general population was high 
school education while in high risk group it was middle school level. The 
general population had a higher level of education but statistically the 
two groups did not show any significant difference (p>0.05). 
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CHART 4: DISTRIBUTION BASED ON EDUCATION 
 
TABLE 6: DISTRIBUTION OF HIGH RISK PATIENTS BASED 
ON RISK FACTORS ASSOCIATED 
RISK FACTOR NO. OF PATIENTS IN HIGH  RISK GROUP 
Female sexual worker 18(33.9%) 
Female having multiple 
sexual partners 
17(32.1%) 
Females with high risk 
partner 9(16.9%) 
Female with other known 
venereal diseases 5(9.4%) 
Female with past history of 
treated venereal diseases 4(7.5%) 
Total 53 
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Female Sex Workers were the most common group among high 
risk women as they are mobilized by NGOs periodically to attend STD 
OPD for their sexual health.  
TABLE 7: DISTRIBUTION BASED ON PARITY 
PARITY 
GENERAL 
POPULATION 
HIGH RISK 
GROUP 
Nulliparous 33(22.4%) 13(24.6%) 
Women with single 
child 
36(24.4%) 8(15.0%) 
Multiparous 78(53.2%) 32(60.4%) 
Total 147 53 
 
Multiparous women were the most common among both the 
groups of women corresponding to the most common age group of 30-39 
years. 
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TABLE 8:  METHODS OF CONTRACEPTION USED 
CONTRACEPTIVE 
GENERAL 
POPULATION 
HIGH-RISK 
GROUP 
None 37(25.3%) 5(9.5%) 
Barrier 
method(Condom) 
10(6.8%) 19(35.9%) 
Oral Contraceptive pills 19(12.9%) 9(16.9%) 
Intra-Uterine 
Contraceptive Device 
24(16.3%) 6(11.3%) 
Permanent Sterilisation 
(Tubectomy) 
57(38.7%) 14(26.4%) 
Total 147 53 
 
Permanent sterilisation by tubectomy was the most common 
contraceptive method used in general group corresponding to more 
number of multiparous women in this group. Barrier method by male 
Condom usage was the common mode of contraception in high risk 
group as it also serves to protect against STIs and is being promoted by 
NACO and NGOs among these groups. 
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CHART 5: METHODS OF CONTRACEPTION USED 
 
TABLE 9:  
DISTRIBUTION BASED ON LABORATORY TEST RESULTS 
 GENERAL POPULATION 
HIGH-
RISK 
GROUPS 
TOTAL 
NO. OF 
SAMPLES 
POSITIVE FOR 
PATHOGEN 
68(46.2%) 37(69.8%) 105(52.5%) 
NORMAL 
VAGINAL 
FLORA 
79(53.8%) 16(30.2%) 95(47.5%) 
TOTAL 147 53 200 
SIGNIFICANCE 
஗2 = 8.665 
P value = 0.0032 
P<0.05 
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The percentage of pathogens identified by wet mount, gram stain 
and culture was significantly higher (p value<0.05) in HRGs when 
compared to the general group who had normal vaginal flora in more than 
half of the cases.  
CHART 6: 
DISTRIBUTION BASED ON LABORATORY TEST RESULTS 
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CHART 7:  
DISTRIBUTION OF ABNORMAL VAGINAL DISCHARGE 
BASED ON PROBABLE INFECTIOUS ETIOLOGY 
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TABLE 10: 
DISTRIBUTION OF ABNORMAL VAGINAL DISCHARGE 
BASED ON PROBABLE INFECTIOUS ETIOLOGY: 
 
GENERAL 
POPULATION 
HIGH-RISK 
GROUP 
TOTAL 
BACTERIAL 
VAGINOSIS 
17(25%) 8(21.6%) 25(23.8%) 
VULVO-VAGINAL 
CANDIDIASIS 
42(61.8%) 17(46%) 59(56.3%) 
TRICHOMONIASIS 0 5(13.5%) 5(4.7%) 
OTHERS 
1-Enterococcus 
(1.5%) 
0 (0%) 1(1%) 
MIXED 
INFECTIONS 
8 (11.7%) 7(18.9%) 15(14.2%) 
TOTAL PATIENTS 
TESTED POSITIVE 
68 37 105 
TOTAL ISOLATES 76 44 120 
 
The most common etiological agent in both the groups was 
Candidiasis (56.3%) followed by Bacterial Vaginosis (23.8%). 
Trichomoniasis was not identified in General group whereas it 
constituted 13.5% of pathogens isolated in HRG. Mixed infections were 
found in both groups constituting about 14.2%.  
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TABLE 11: BACTERIAL VAGINOSIS BY AMSEL’S CRITERIA 
AMSEL’S 
CRITERIA 
GENERAL 
POPULATION 
HIGH-RISK 
GROUP 
TOTAL 
3 or more positive 36(24.5%) 18(33.9%) 54(27%) 
Less than 3 111(75.5%) 35(66.1%) 146(73%) 
TOTAL 147 53 200 
 
According to Amsel’s criteria if 3 out of 4 criteria are fulfilled, it is 
suggestive of BV. Amsel’s criteria identified 27% of patients as having 
BV. 
TABLE 12:  
BACTERIAL VAGINOSIS BY NUGENT’S SCORING OF GRAM 
STAINED VAGINAL SMEARS 
NUGENT’S 
SCORE 
GENERAL 
POPULATION 
HIGH-RISK 
GROUP 
TOTAL 
0-3(Normal Flora) 74(50.3%) 20(37.7%) 94(47%) 
4-6(Intermediate) 48(32.6%) 18(34%) 66(33%) 
7-10(BV) 25(17.1%) 15(28.3%) 40(20%) 
TOTAL 147 53 200 
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Nugent’s score identified 20% of samples to be BV, 33% 
intermediate flora and 47% as normal flora. 
 
CHART 8: BACTERIAL VAGINOSIS – NUGENT’S SCORE 
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TABLE 13: 
COMPARISON BETWEEN AMSEL’S CRITERIA & NUGENT’S 
CRITERIA 
BACTERIAL 
VAGINOSIS 
BY 
AMSEL’S 
CRITERIA 
BY 
NUGENT’S 
CRITERIA 
GENERAL 
POPULATION 
36 25 
HIGH RISK GROUP 18 15 
TOTAL 54 40 
 
Amsel’s criteria identified more cases of BV than Nugent’s criteria 
but Nugent’s scoring is widely accepted as the Gold standard for 
diagnosis of BV. 
TABLE 14: DISTRIBUTION OF CANDIDIASIS 
VULVO-VAGINAL 
CANDIDIASIS 
GENERAL 
POPULATION 
HIGH-RISK 
GROUP 
TOTAL 
Candida albicans 21(42%) 11(47.8%) 32(43.8%) 
Non albicans Candida 29(58%) 12(52.2%) 41(56.2%) 
TOTAL 50 23 73 
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NAC(56.2%) were more commonly isolated than C. albicans 
(43.8%) among both the groups. 
 
TABLE 15: CANDIDA SPECIATION 
 
CANDIDA 
SPECIES 
NO. OF ISOLATES 
NORMAL 
POPULATION 
HIGH RISK 
GROUPS 
TOTAL 
C. Albicans 21(42%) 11 (47.8%) 32 (43.8%) 
C. Tropicalis 10(20%) 4 (17.4%) 14 (19.3%) 
C. Glabrata 9(18%) 3 (13.1%) 12 (16.4%) 
C. Krusei 6(12%) 3 (13.1%) 9 (12.3%) 
C. Parapsilosis 4(8%) 2 (8.6%) 6 (8.2%) 
TOTAL 50 23 73 
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Speciation of Candida was done based on Germ tube test, 
CHROMagar and CornMeal agar. C. albicans was the most common 
species (43.8%)isolated in both the groups. Among the NAC, C. 
tropicalis (19.3%) was most commonly isolated. 
 
TABLE 16:  DISTRIBUTION OF TRICHOMONIASIS 
 
BY WET 
MOUNT 
BY 
GIEMSA 
BY 
CULTURE 
NORMAL 
POPULATION 
0 0 0 
HIGH RISK GROUP 5 5 6 
TOTAL 5 5 6 
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Culture of Trichomonas in CPLM broth was the most sensitive as 
one case missed by wet mount examination and giemsa stain probably 
due to low parasite load or reduced motility was identified after culture of 
vaginal discharge for 4 days. 
 
TABLE 17:  
DISTRIBUTION BASED ON NO. OF PATHOGENS ISOLATED 
FROM A PATIENT 
PATHOGEN 
GENERAL 
POPULATION 
HIGH-RISK 
GROUPS 
TOTAL 
SINGLE 60(88.2%) 30(81.1%) 90 
MIXED 
INFECTION 
8- 8 
(BV & Candida)  
(11.7%) 
7(18.9%) 
-1(2.7%) (TV&BV) 
-6(16.2%)(BV & 
Candida) 
15 
TOTAL 68 37  
 
5
5
6
CHART 11:   DIAGNOSIS OF     
TRICHOMONIASIS
WET MOUNT GIEMSA CULTURE
72 
 
Mixed infections were found in both groups ( 14.2%). Of this,  
co-infection of BV and Candidiasis was most common- 11.7% in general 
group and 16.2% in HRG. 
CHART 12: 
DISTRIBUTION BASED ON SINGLE OR MULTIPLE 
INFECTIONS 
 
TABLE 18: DISTRIBUTION BASED ON HIV STATUS 
HIV STATUS 
NORMAL 
POPULATION 
HIGH RISK 
GROUPS 
NEGATIVE 147(100%) 51(96.2%) 
POSITIVE 0 2(3.8%) 
TOTAL 147 53 
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TABLE 19: DISTRIBUTION BASED ON RPR/TPHA POSITIVITY 
SYPHILIS 
NORMAL 
POPULATION 
HIGH RISK 
GROUPS 
NEGATIVE 147 (100%) 48 (90.5%) 
POSITIVE 0 5 (9.5%) 
TOTAL 147 53 
 
None of the patients in general group had syphilis or HIV. This 
shows low prevalence of these diseases in general population without any 
risk factors. 
CHART 13: 
HIV AND SYPHILITIC STATUS OF HIGH RISK INIDIVIDUALS
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DISCUSSION 
Abnormal Vaginal discharge is one of the most common but often 
neglected health problem in women in their reproductive age. Therefore 
it is important to know the exact prevalence of AVD in women with 
genital tract infections.  This study is carried out to determine the 
characteristics of vaginal discharge and the prevalence of pathogens 
causing infectious vaginal discharge.   
In the present study, total number of patients were 200 of which 
147 (73.5%) patients belonged to general population with no significant 
risk factors and 53 (26.5%) patients belonged to high risk groups  
(Table 1). 
Among these 200 patients included in the study, 146 (73%) 
presented with abnormal vaginal discharge as the chief presenting 
complaint whereas 54(27%) presented with other complaints like lower 
abdominal pain, infertility, irregular menstrual cycle and dysuria and 
were found to have abnormal vaginal discharge on examination. (Table 
2) In a study by Das et al, 68% were symptomatic with AVD and 32 % 
were asymptomatic which is similar to the finding in this study.32 
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Among the 200 patients, 102(69%) from Gynaecology OPD and 
44(83%) from STD OPD had abnormal vaginal discharge as the chief 
presenting complaint whereas 45(31%) from Gynaecology OPD and 
9(17%) from STD OPD presented with other complaints like lower 
abdominal pain, infertility or irregular menstruation and were found to 
have AVD on examination. (Table 2) This shows higher awareness 
among women in high risk groups about the nature of vaginal discharge 
and for seeking medical services.  
The study included menstruating women of reproductive age group 
from 18 years to 45 years as they are most vulnerable to acquire STIs.  
The commonest age group in both the study groups was 30-39 years. Of 
the 147 women from Gynaecology OPD, 61(41%) belonged to age group 
of 30-39 and of the 53 women from STD OPD, 25 (47%) belonged to age 
group of 30-39. The next common age group was 18-29 years, 58(39%) 
of general population and 18(33%) of high risk groups belonged to this 
age group.(Table 3) 
The most common age group coincides with the study by Samia S. 
Khamees et al. in which the mean age was 30.8 and the highest 
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prevalence of STD (32%)  has been found in the age group of 29 - 33 
years.33   
This is also in accordance with a study by R Sivaranjani et al. 
where the mean age was 35.24 ± 4.37 years.34 This is attributed to higher 
sexual activity in this age group.  
Based on marital status (Table 4), in both the groups married 
women formed the majority. 92.5% of general group and 45.2% of high 
risk group were married and living with their husband. There were no 
unmarried women in general group whereas 9.4% of high risk group were 
unmarried. The widowed (13.2%) and separated women (32.2%) were 
more in number in the high risk group than general group [widowed 
(2%), separated (5.4%)]. These findings are similar to a study by 
Madeline Sutton et al.35 where percentage of widows and separated 
females was higher in high risk groups. 
The educational status analysis (Table 5) of both the groups 
showed that majority (31.3%) of general population had completed high 
school whereas middle school education was more common among high 
risk group (32.1%). Overall, Literacy was significantly lower in the high 
risk group than general population. This is similar to the findings of the 
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study by Bambara Moussa et al. where 31.8% of high risk women had 
only middle school education.36 Many of the female sex workers also 
cited lack of education and means of livelihood as one of the reasons for 
entering sex work.  
Among the high risk groups,(Table 6) most common were the 
female sexual workers (33.9%), next common high risk factor was 
females with multiple sexual partners (32.1%), followed by females with 
high risk partners (16.9%).  This is because of the efforts put in by the 
Non Government Organisations (NGO) in mobilizing the Female Sexual 
Workers (FSW) to attend STD OPD and creating an awareness about 
sexual health among them. 
Comparing the parity (Table 7), in both groups multi-parous 
women formed the majority with 53.2% of general group and 60.4% of 
high risk group. In the general group permanent sterilization by 
tubectomy was the most common method of contraception whereas 
barrier method by condom usage was most common contraceptive 
method used in high risk group (Table 8).  
This is similar to the study by Bambara Moussa et al. where male 
condom was the most commonly adopted practice among high risk group 
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women.36 No contraceptive methods were adopted in 25.3% of general 
group and 9.5% of high risk group. In this context, Barrier methods are 
considered to be better as they provide protection against transmission of 
STD in addition to contraception.  
Of the 200 patients tested (Table 9), 105 (52.5%) were positive for 
potential pathogens and 95 (47.5%) did not show any pathogenic 
organisms and had only normal vaginal flora. Of the 105 patients tested 
positive for pathogens, 68 were from general group and 37 were high risk 
individuals. 79(53.8%) of general group and 16 (30.2%) of high risk 
group showed normal vaginal flora. This is similar to a study by R 
Sivaranjani et al. in which infectious agents were found in 51.75% 
patients.34  
Of the 146 patients who presented with AVD, 76(52.1%) patients 
tested positive for pathogens. Of the 54 patients who presented with other 
complaints like lower abdominal pain, infertility or irregular 
menstruation and found to have AVD on examination, 29(53.7%) tested 
positive for pathogens. 
Out of the 105 patients (52.5%) positive for pathogens, 25 patients 
(23.8%) were found to have Bacterial Vaginosis, 59(56.3%) patients had 
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VVC, 5(4.7%) had Trichomoniasis, 1(1%) had Enterococcal infection, 
15(14.2%) had mixed infections with more than pathogen. (Table 10) 
This is similar to a study by Fonck et al.37 where Candidiasis was found 
to be more prevalent (50%) among reproductive age group women. It is 
in contrast to a study by Bhalla et al.38 where the most common infection 
was BV (32.8%), followed by candidiasis (16.9%) and trichomoniasis 
(2.8%) cases. 
The rise in VVC as a major cause of AVD could be due to 
increased use of broad spectrum antibiotics for various health reasons 
which alter the normal vaginal flora leading to positive shift in 
colonization of yeast.39 This could account for an increase in VVC over 
BV as the leading cause of abnormal Vaginal Discharge.  
In this study, (Table 11) Amsel’s criteria identified 54 patients 
(27%) to have clinical findings suggestive of BV.  
By Nugent’s scoring, (Table  12) 40 smears (20%) had a score of 
7-10 and confirmed to have BV in which 25(17.1%) belonged to general 
group and 15 (28.3%) belonged to high risk group. 94 smears (47%) 
showed a score of 0-3 (Normal Flora). 66 smears(33%) had a 
intermediate score of 4-6 and these patients should be followed up and 
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gram stain should be repeated to detect progression to BV. This is in 
accordance with a study by P Madhivanan et al. in which 19.1% had BV, 
65.4% had normal flora and 15.4% had intermediate flora.41 
Bacterial Vaginosis can be diagnosed bedside by clinical criteria 
such as Amsel’s criteria but Nugent’s laboratory method is the Gold 
standard for diagnosis of BV. Rangari et al. in their study reported 
Nugent score had a higher sensitivity in diagnosis of BV while Amsel’s 
criteria had less sensitivity but higher specificity. They concluded 
Amsel’s criteria without using staining methods for detection of ‘clue 
cells’ could be misleading.40 
Total number of Candida spp. isolated were 73 out of which 
32(43.8%) were Candida albicans and 41(56.2%) were non albicans 
Candida. (Table 14)  Of the non albicans Candida, most common was  
C. tropicalis(19.3%), followed by C. glabrata (16.4%), C. krusei(12.3%) 
and C. parapsilosis(8.2%). (Table 15) Thus, Candida albicans is the most 
common species isolated followed by C. tropicalis and C.glabrata and C. 
krusei. 
This is in accordance with a study by Oyeyipo et al.50 in which 
Candida albicans (35.0%) was the predominant species followed by C. 
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tropicalis (8.3%), C. glabrata (6.7%) and C. krusei (3.3%). Also, the 
study by Doddaiah Vijaya et al. showed C. tropicalis to be the most 
common non albicans species isolated from VVC.42 
This study shows a marked rise in proportion of NAC infections as 
compared to previous studies like the study by Twinkle n. Gandhi et al. 
where C. albicans was 66.39% of Candida isolates and NAC formed 
33.61%.43 
The reason for this may be the indiscriminate over-the-counter 
usage of antifungals like Fluconazole which destroys the more sensitive 
Candida albicans and selects the less sensitive non albicans species. The 
resistance to azole groups among the non albicans Candida is on the rise 
and thus their identification becomes mandatory. 
The speciation was done with commercially available 
CHROMagar which  has  several  advantages  like  direct  identification  
of species and rapidity, rendering it useful for early identification and 
treatment of Candidial infection.44 These results also correlated well with 
the Corn meal agar test and the Candida speciation was thus confirmed 
with the results of both CHROMagar and Corn meal agar. 
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Trichomoniasis was better identified by culture in CPLM than by 
direct examination by wet mount. (Table 16)  Total isolates were 6(5.7%) 
in which 5(4.7%) were identified by wet mount examination, giemsa 
stain and culture. One isolate was identified only after culture on CPLM. 
This shows greater sensitivity by Culture methods which are the gold 
Standard for diagnosis of trichomoniasis. This is similar to a study by 
Van der Schee C et al. in which wet mount microscopy detected 3.8% 
Trichomonas infection as opposed to 4.9% positives in modified 
Diamond's medium.45  
Mixed infections with more than 1 pathogen were seen in 15 
patients (14.2%). 8 patients in the general population and 6 patients in 
high risk group had co-infection of BV and Candidiasis. One patient in 
the high risk group had co-infection of TV and BV. (Table 17)    
None of the women in general population were HIV positive 
whereas 2(3.8%) patients in high risk group were known HIV positive. 
(Table 18) 
Similarly, none of the women in general population were positive 
for RPR/TPHA whereas 5(9.5%) patients in high risk group were 
positive. (Table 19)  These served as additional risk factors in the high 
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risk groups consistent with promiscuous sexual practices not seen in 
general population. 
PREDISPOSING FACTORS: 
Majority of the women reported usage of sanitary napkins during 
menstruation than cloth napkins or tampons. None of the women reported 
douching practice. This improvement in personal hygiene could also be 
one of the reasons for decrease in BV prevalence in this locality since 
douching is consistently associated with BV as shown in the study by 
Mark A. Klebanoff et al.46 
There was a positive correlation between Diabetes mellitus and 
Candidiasis in this study. Out of the 73 patients with candidiasis, 
13(17.8%) patients gave a positive history of Diabetes. Different studies 
such as the study by Reza Faraji et al. have indicated VVC is more 
common in women with diabetes than in the normal population. 47  
In this study, Trichomonas vaginalis was isolated only from High 
risk women and not from general population. This shows Trichomoniasis 
being a sexually transmitted disease is more prevalent in women with 
promiscuous sexual practices. High-risk sexual behaviour is positively 
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associated with Trichomoniasis as reported by Phuong Anh Ton  
Nu et al.48     
 One patient had Enterococcus as the sole cause of Abnormal 
Vaginal discharge. She was a neglected woman with history of induced 
abortion one month ago. Personal hygiene was very poor. On 
examination, there was excessive, inspissated, dirty white, foul smelling 
vaginal discharge. Culture showed heavy growth of Enterococcus faecalis 
which was sensitive to penicillin, ampicillin, high level gentamycin, 
vancomycin and resistant to ciprofloxacin. She was treated with 
Penicillin and soon symptomatically improved. 
 
 
 
 
 
 
 
SUMMARY 
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SUMMARY 
¾ This study on infectious etiology of Abnormal Vaginal Discharge 
(AVD) in women of reproductive age group was conducted to 
determine the prevalence of AVD and its etiological agents among 
two groups of women. 
¾ One group of women attending Gynaecology OPD without 
significant risk factors were representative of general population 
and the other group of women with associated high risk factors 
attending STD OPD was representative of the High Risk Groups 
(HRG). 
¾ The general group consisted of 147 women and the High risk 
group consisted of 53 women. 
¾ Of the 200 patients tested, 52.5% were positive for pathogens and 
47.5% did not show any potential pathogens.  
¾ The most common etiological agent in both the groups was 
Candidiasis(56.3%). 
¾ The second most common etiology was Bacterial Vaginosis 
(23.8%). 
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¾ Trichomoniasis was not identified in General group whereas it 
constituted 13.5% of pathogens isolated in HRG. 
¾ Mixed infections were found in both groups constituting about 
14.2%. Of this, co-infection of BV and Candidiasis was most 
common- 11.7% in general group and 16.2% in HRG. 
¾ In BV, Amsel’s clinical criteria (27%) identified more number of 
cases than Nugent’s scoring method (20%) but the laboratory 
scoring of gram stained smear is considered the gold standard. 
¾ Candidiasis was most common etiological agent causing AVD in 
this study. This could be due to indiscriminate use of antibiotics 
leading to a shift towards fungal pathology. Though Candida 
albicans (43.8%) was the most common species identified, there is 
a significant rise in non albicans Candida (NAC) species. This is 
probably due to over-usage of fluconazole being included in the 
Green kit for vaginal discharge syndrome which may selectively 
increase growth of fluconazole resistant NAC.52 
¾ Trichomoniasis was better identified by culture in CPLM medium 
than by wet mount examination in which one case with low 
parasite load was missed and later identified in culture. 
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¾ HIV and syphilis was not documented in general population 
whereas 3.8% HIV positivity and 9.5% RPR/TPHA positivity was 
seen in high risk groups.  
¾ Overall, the positivity for pathogens was more in HRG with 69.8% 
as opposed to general population (46.2%) 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION 
This study was done with the aim of determining the various 
causes of infectious vaginal discharge among general population and high 
risk groups and Candidiasis was found to be the most common etiological 
agent in both the groups followed by Bacterial Vaginosis. Co-infections 
with Candidiasis and BV were also seen in a fair proportion of patients in 
both groups. Trichomoniasis, HIV and Syphilis were seen only in 
individuals with high risk. Gonococcal infection was not detected in both 
the groups.  
There is a significant difference between the number of pathogen 
positive cases among general population and high risk population. High 
risk individuals were significantly more prone to infections. There is an 
urgent need to spread awareness among high risk groups of the need for 
use of preventive measures and to decrease their risk activity. 
Syndromic management still remains the mode of treatment for 
vaginal discharge syndrome and it does provide adequate antibiotic cover 
in many cases. But, it is mandatory to investigate the non-responders to 
syndromic management and give appropriate therapy. 
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However, in view of increasing incidence of non albicans Candida 
with decreased sensitivity to fluconazole, without the etiological 
diagnosis and susceptibility testing these patients cannot be treated 
properly. This is more important in case of C.krusei which is intrinsically 
resistant to fluconazole. In such cases, voriconazole and itraconazole are 
the drugs of choice which is not included in the Green kit used in 
Syndromic management of Vaginal Discharge syndrome. 
Also, Syndromic approach causes over-exposure to drugs for 
infections not harboured by the patient and in the long run leads to 
development of resistance in the microorganisms.  
Prompt diagnosis and treatment of Genito- Urinary infections will 
prevent a lot of distress to the patient. Delayed or inadequate treatment 
may lead to serious complications like PID causing infertility, increased 
risk of ectopic pregnancies, abdominal discomfort and chronic pelvic 
pain. 
Infectious vaginal discharge in pregnant women can lead to 
PROM, IUGR, IUD, preterm labour and repeated miscarriages.  
Abnormal Vaginal Discharge being an often overlooked symptom 
among women needs to be addressed as an important issue. Women with 
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abnormal vaginal discharge hesitate to seek medical assistance until the 
complaint becomes intolerable and hinders routine activities.49 
Thus, it is essential to spread awareness about the predisposing 
factors, symptoms and easily available treatment of AVD among women 
particularly targeting the sexually active and reproductive age groups to 
reduce mortality and morbidity in mother and baby. 
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ANNEXURES 
  
PROFORMA 
                                                                                                                
Serial No:                            
1)Name: 
   Date: 
2) Age   :                                                                                      
3) Gender:                                                                                  
4) OP   No:   
5) PIN No:     
                                                                 
HISTORY DETAILS: 
 
 
6) H/O abnormal vaginal discharge (Yes/No): Colour, consistency, odour 
7) H/O itching(Yes /No): 
8) H/O foul-odour (Yes/No): 
               /200 
9) H/O lower abdominal pain  (Yes/No): 
10) H/O dyspareunia  (Yes/No): 
11)H/O antibiotic use (Yes/No): 
12) H/O comorbid illness(Yes/No): 
MENSTRUAL HISTORY: 
Age at menarche: 
Last menstrual period: 
MARITAL HISTORY: 
Married since: 
No. of children:    
Last child birth: 
Last marital contact: 
Extra marital contact: 
Pre marital contact: 
 
 
GENERAL EXAMINATION : 
Anaemia                                                 (Yes/No): 
Jaundice                                                  (Yes/No): 
Generalised Lymphadenopathy              (Yes/No): 
 
SYSTEMIC    EXAMINATION   
RESPIRATORY  SYSTEM          : 
CARDIOVASCULAR SYSTEM : 
CENTRAL NERVOUS SYSTEM :  
PER ABDOMEN EXAMINATION:                            
PER VAGINAL EXAMINATION : 
PER SPECULUM EXAMINATION : 
INVESTIGATIONS: 
 
 
TREATMENT: 
CONSENT FORM 
I agree to participate in the study entitled “A STUDY ON THE 
INFECTIOUS ETIOLOGY OF ABNORMAL VAGINAL 
DISCHARGE IN WOMEN OF REPRODUCTIVE AGE GROUP 
ATTENDING A TERTIARY CARE HOSPITAL”. I confirm that  
I have been told about this study in my mother tongue and have had the 
opportunity to clarify my doubts. 
I understand that my participation is voluntary and I may refuse to 
participate at any time without giving any reasons and without affecting 
my benefits. 
I agree not to restrict the use of any data or results that arise from 
this study. 
 
 
 
Name of the participant: Sign / Thumb print: 
Name of the investigator:  
Sign of Investigator: 
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MASTER CHART 
  
KEY TO MASTER CHART 
CONTRA -  CONTRACEPTIVE USED 
EDU   -  EDUCATION 
AVD   -  ABNORMAL VAGINAL DISCHARGE 
LAP  - LOWER ABDOMINAL PAIN 
INF   -  INFERTILITY 
IM   - IRREGULAR MENSTRUATION 
MARITAL - MARITAL STATUS 
M   -  MARRIED 
W   - WIDOWED 
S  - SEPARATED 
UN   -  UNMARRIED 
PL   - PARA LIVE 
OCP   -  ORAL CONTRACEPTIVE PILLS 
TUBECT -  TUBECTOMY 
IUCD  -  INTRA UTERINE CONTRACEPTIVE DEVICE 
ILL   -  ILLITERATE 
PRI   -  PRIMARY 
MID   -  MIDDLE SCHOOL 
HS   - HIGH SCHOOL 
HSEC  -  HIGHER SECONDARY 
DEG  -  DEGREE 
FSW  -  FEMALE SEXUAL WORKER 
HRP   -  FEMALE WITH HIGH RISK PARTNER 
MSP   -  FEMALE WITH MULTIPLE SEXUAL PARTNER 
PVD   - FEMALE WITH PAST VENEREAL DISEASE 
VD   -  FEMALE WITH KNOWN VENEREAL DISEASE 
BYC  -  BUDDING YEAST CELLS 
PH   -  PSEUDOHYPHAE 
PUS   -  PUS CELLS 
NF   -  NORMAL FLORA 
INT   -  INTERMEDIATE FLORA 
BV   -  BACTERIAL VAGINOSIS 
C.ALB -  CANDIDA ALBICANS 
C.TROP - C. TROPICALIS 
C.GLAB -  C.GLABRATA 
C.KRU -  C. KRUSEI 
C.PARA -  C.PARAPSILOSIS 
VVC   -  VULVO VAGINAL CANDIDIASIS 
TV   -  TRICHOMONAS VAGINALIS 
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23 32860 41 AVD M P3L3 TUBECT HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - - VVC24 33686 18 IM M P0L0 NIL HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF25 33723 45 LAP W P2L2 TUBECT ILL - NORMAL BYC PUS,BYC <3 INT C.GLAB Ǧ - + VVC26 34106 19 AVD M P0L0 NIL HSEC - NORMAL BYC,PH PUS,BYC,PH <3 NF C.TROP Ǧ - - VVC27 34118 30 INF M P0L0 NIL DEG - NORMAL - NORMAL <3 INT Ǧ - - NF28 34111 42 AVD M P3L2 TUBECT MID - CLUE BYC,PH CLUE,PUS,BYC 3+ BV C.PARA Ǧ - - VVC+BV29 34188 26 AVD M P1L1 CONDOM DEG - NORMAL BYC PUS,BYC <3 NF C.GLAB Ǧ - - VVC30 35144 37 AVD M P2L2 TUBECT PRI - NORMAL - NORMAL <3 NF Ǧ - - NF31 35171 19 INF M P0L0 NIL HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF32 35162 40 AVD M P2L2 TUBECT PRI - NORMAL BYC,PH PUS,BYC,PH <3 NF C.TROP Ǧ - - VVC33 35375 35 AVD M P2L2 TUBECT MID - NORMAL - NORMAL <3 NF Ǧ - - NF34 35452 21 INF M P0L0 NIL DEG - NORMAL - NORMAL 3+ INT Ǧ - - NF35 35365 30 AVD M P2L2 IUCD HS - NORMAL - NORMAL <3 INT Ǧ - - NF36 35428 20 AVD M P1L1 OCP HSEC - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - - VVC37 35479 35 IM M P2L2 TUBECT DEG - CLUE - CLUE 3+ BV Ǧ - - BV38 35468 23 LAP M P1L1 IUCD HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF39 35945 39 AVD M P2L2 OCP ILL - NORMAL BYC,PH NORMAL <3 NF C.PARA Ǧ - - VVC40 35969 26 AVD M P1L1 CONDOM DEG - CLUE - CLUE 3+ BV Ǧ - - BV41 35981 37 AVD M P2L2 CONDOM MID - NORMAL - NORMAL <3 NF Ǧ - - NF42 35993 40 IM M P4L3 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - - NF43 35942 32 INF M P0L0 NIL HSEC - NORMAL BYC PUS,BYC,PH 3+ INT C.GLAB Ǧ - + VVC44 35615 30 AVD M P2L2 IUCD MID - NORMAL - NORMAL <3 NF Ǧ - - NF45 35598 21 AVD M P0L0 NIL DEG - NORMAL - NORMAL <3 INT Ǧ - - NF
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46 37079 25 AVD M P1L1 OCP HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF47 37140 37 AVD M P3L3 TUBECT HS - CLUE BYC,PH CLUE,PUS,BYC 3+ BV C.ALB Ǧ - + VVC+BV48 37135 40 AVD M P2L2 TUBECT PRI - NORMAL - NORMAL <3 NF Ǧ - - NF49 37307 38 AVD M P3L3 TUBECT HS - NORMAL - NORMAL 3+ INT Ǧ - - NF50 37323 37 IM M P2L2 TUBECT HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF51 1594 30 AVD M P2L2 TUBECT HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.TROP Ǧ - - VVC52 1593 42 IM M P0L0 NIL PRI - NORMAL - NORMAL <3 NF Ǧ - + NF53 1607 29 AVD M P2L2 IUCD DEG - CLUE BYC,PH CLUE 3+ BV C.PARA Ǧ - - VVC+BV54 1802 31 INF M P1L1 NIL HS - NORMAL BYC PUS,BYC <3 NF C.KRU Ǧ - - VVC55 1734 26 LAP M P1L1 IUCD DEG - NORMAL - NORMAL <3 INT Ǧ - - NF56 1793 34 AVD S P2L2 CONDOM HS - NORMAL - NORMAL <3 INT Ǧ - - NF57 1792 29 AVD M P1L1 OCP HSEC - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - - VVC58 2005 32 AVD M P2L2 TUBECT MID - CLUE - CLUE 3+ BV Ǧ - - BV59 2043 28 AVD M P1L1 OCP HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.TROP Ǧ - - VVC60 2037 18 AVD M P0L0 NIL HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF61 2039 38 IM M P1L1 IUCD DEG - CLUE - CLUE 3+ BV Ǧ - - BV62 2042 40 AVD M P3L3 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - + NF63 2045 24 AVD M P1L1 OCP DEG - NORMAL BYC,PH PUS,BYC,PH <3 INT C.TROP Ǧ - - VVC64 2048 37 AVD M P2L2 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - + NF65 2053 23 IM M P0L0 NIL HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF66 2047 29 AVD M P2L2 TUBECT DEG - CLUE - CLUE 3+ BV Ǧ - - BV67 2059 23 INF M P0L0 NIL DEG - NORMAL BYC PUS,BYC <3 INT C.GLAB Ǧ - - VVC68 2062 20 AVD M P0L0 NIL HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF
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69 2063 31 AVD M P2L2 TUBECT MID - CLUE BYC,PH CLUE,BYC,PH 3+ BV C.ALB Ǧ - - VVC+BV70 2078 19 AVD M P0L0 NIL HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF71 2076 45 IM M P2L2 TUBECT ILL - NORMAL - NORMAL <3 NF Ǧ - - NF72 2014 20 AVD M P0L0 NIL HSEC - CLUE - CLUE 3+ BV Ǧ - - BV73 2089 30 AVD M P2L2 TUBECT DEG - NORMAL - NORMAL <3 NF Ǧ - - NF74 2095 29 IM M P2L2 CONDOM PRI - NORMAL - NORMAL <3 INT Ǧ - - NF75 2101 35 LAP M P3L2 TUBECT MID - NORMAL BYC,PH PUS,BYC,PH 3+ INT C.ALB Ǧ - + VVC76 2145 27 AVD M P1L1 IUCD DEG - NORMAL - NORMAL <3 INT Ǧ - - NF77 2149 37 AVD M P2L2 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - - NF78 2188 40 AVD S P3L3 TUBECT PRI - CLUE BYC,PH CLUE,BYC,PH 3+ BV C.TROP Ǧ - - VVC+BV79 2189 28 INF M P0L0 NIL DEG - NORMAL - NORMAL <3 NF Ǧ - - NF80 2191 21 AVD M P0L0 NIL HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF81 2264 41 AVD M P2L2 TUBECT MID - NORMAL BYC,PH PUS,BYC,PH <3 INT C.ALB Ǧ - + VVC82 2269 28 AVD M P1L1 OCP HS - CLUE BYC,PH CLUE,BYC,PH 3+ BV C.ALB Ǧ - - VVC+BV83 2276 31 AVD M P1L1 IUCD MID - BYC,PH BYC,PH BYC,PH <3 NF C.TROP Ǧ - - VVC84 2277 42 IM M P2L2 TUBECT PRI - NORMAL - NORMAL <3 NF Ǧ - + NF85 2279 30 AVD M P1L1 OCP MID - NORMAL BYC,PH PUS,BYC,PH <3 INT C.KRU Ǧ - - VVC86 2283 27 LAP M P1L1 CONDOM HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF87 2291 35 AVD M P2L2 TUBECT HS - CLUE BYC,PH CLUE 3+ BV C.PARA Ǧ - - VVC+BV88 2297 43 AVD M P3L3 TUBECT PRI - NORMAL - NORMAL 3+ NF Ǧ - - NF89 2299 26 AVD M P1L1 OCP DEG - NORMAL BYC,PH PUS,BYC,PH <3 INT C.ALB Ǧ - - VVC90 2371 25 AVD M P1L1 IUCD HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF91 2374 41 AVD M P2L2 TUBECT PRI - CLUE - CLUE 3+ BV Ǧ - - BV
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92 2379 22 INF M P0L0 NIL DEG - NORMAL - NORMAL <3 INT Ǧ - - NF93 2364 42 AVD M P2L2 TUBECT HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - + VVC94 2387 40 AVD M P2L2 TUBECT PRI - NORMAL - NORMAL 3+ INT Ǧ - - NF95 2389 36 AVD S P2L2 TUBECT HS - CLUE - CLUE 3+ BV Ǧ - - BV96 2395 28 IM M P1L1 OCP HSEC - NORMAL BYC,PH PUS,BYC,PH <3 NF C.TROP Ǧ - - VVC97 2398 30 AVD M P2L2 IUCD HS - NORMAL BYC,PH PUS,BYC,PH <3 INT C.ALB Ǧ - - VVC98 2399 21 AVD M P0L0 NIL DEG - NORMAL - NORMAL <3 NF Ǧ - - NF99 2411 30 INF M P0L0 NIL HS - NORMAL - NORMAL <3 INT Ǧ - - NF100 2412 21 INF M P0L0 NIL HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF101 2420 37 AVD M P2L2 TUBECT HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - - VVC102 2456 19 AVD M P0L0 NIL HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF103 2445 44 IM M P3L3 TUBECT ILL - NORMAL - NORMAL <3 NF Ǧ - - NF104 2500 38 AVD S P2L2 NIL PRI - NORMAL BYC,PH PUS,BYC,PH <3 NF C.TROP Ǧ - - VVC105 2512 26 AVD M P1L1 OCP HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF106 2510 30 IM M P2L2 TUBECT HS - NORMAL BYC PUS,BYC <3 NF C.GLAB Ǧ - - VVC107 2528 43 AVD M P2L2 TUBECT PRI - NORMAL - NORMAL <3 NF Ǧ - + NF108 2588 21 AVD M P0L0 NIL HSEC - CLUE - CLUE 3+ BV Ǧ - - BV109 2589 28 LAP M P1L1 OCP HS - NORMAL - NORMAL <3 NF Ǧ - - NF110 2594 39 AVD S P2L2 TUBECT HS - CLUE BYC,PH CLUE,BYC 3+ BV C.ALB Ǧ - - VVC+BV111 2599 42 AVD M P3L3 TUBECT PRI - NORMAL - NORMAL <3 NF Ǧ - - NF112 2597 31 AVD M P2L2 TUBECT HS - NORMAL - NORMAL 3+ INT Ǧ - - NF113 2613 25 AVD M P1L1 OCP HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF114 2617 30 INF M P0L0 NIL HS - NORMAL - NORMAL <3 INT Ǧ - - NF
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115 2627 41 AVD M P2L2 TUBECT HS - NORMAL BYC,PH PUS,BYC,PH <3 INT C.ALB Ǧ - + VVC116 2625 26 AVD M P2L2 IUCD HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF117 2629 24 AVD M P1L1 NIL HS - NORMAL BYC PUS,BYC <3 NF C.GLAB Ǧ - - VVC118 2633 30 AVD M P2L2 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - - NF119 2638 35 AVD M P2L2 TUBECT PRI - NORMAL - NORMAL <3 NF Ǧ - - NF120 2645 40 AVD M P2L2 TUBECT MID - CLUE - CLUE 3+ BV Ǧ - - BV121 2699 32 LAP M P2L2 OCP HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF122 2714 22 AVD M P0L0 NIL HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - - VVC123 2708 37 AVD M P2L2 TUBECT PRI - CLUE - CLUE 3+ BV Ǧ - - BV124 2719 34 AVD M P2L2 TUBECT PRI - CLUE - CLUE 3+ BV Ǧ - - BV125 2725 31 INF M P0L0 NIL HSEC - NORMAL BYC PUS,BYC <3 NF C.GLAB Ǧ - - VVC126 2726 22 AVD M P0L0 NIL HSEC - NORMAL - NORMAL <3 INT Ǧ - - NF127 2728 30 AVD M P2L2 TUBECT HS - NORMAL BYC,PH PUS,BYC,PH <3 INT C.KRU Ǧ - + VVC128 2745 25 LAP M P1L1 CONDOM HS - NORMAL - NORMAL <3 NF Ǧ - - NF129 2611 30 LAP M P2L2 IUCD MID - NORMAL BYC,PH PUS,BYC,PH <3 INT C.KRU Ǧ - - VVC130 2751 25 AVD M P1L1 OCP HSEC - NORMAL - NORMAL <3 NF Ǧ - - NF131 2822 36 IM M P2L2 TUBECT PRI - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - + VVC132 2826 24 AVD M P1L1 CONDOM HS - NORMAL - NORMAL <3 INT Ǧ - - NF133 2831 37 LAP S P2L2 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - - NF134 2839 38 AVD M P2L2 TUBECT PRI - NORMAL BYC,PH PUS,BYC,PH <3 NF C.KRU Ǧ - - VVC135 2841 27 AVD M P2L2 IUCD HS - CLUE - CLUE 3+ BV Ǧ - - BV136 2844 37 AVD M P1L1 IUCD PRI - NORMAL - NORMAL <3 NF Ǧ - - NF137 2846 24 AVD M P2L2 IUCD HS - NORMAL - NORMAL <3 NF Ǧ - - NF
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138 2852 30 IM M P2L2 TUBECT MID - NORMAL BYC BYC <3 NF C.GLAB Ǧ - - VVC139 3381 21 AVD M P1L1 IUCD HS - NORMAL - NORMAL <3 NF Ǧ - - NF140 3401 31 AVD M P2L2 TUBECT HS - NORMAL - NORMAL <3 INT Ǧ - - NF141 3514 19 AVD M P1L1 NIL HS - NORMAL - NORMAL <3 NF Ǧ - - NF142 3557 30 IM M P3L2 IUCD HS - NORMAL BYC,PH PUS,BYC,PH <3 NF C.ALB Ǧ - - VVC143 3761 30 INF M P0L0 NIL HS - NORMAL - NORMAL <3 NF Ǧ - - NF144 3773 29 AVD M P2L2 TUBECT HS - NORMAL - NORMAL <3 NF Ǧ - - NF145 3792 35 LAP M P2L2 TUBECT MID - CLUE - CLUE 3+ BV Ǧ - - BV146 3729 19 AVD M P1L1 NIL HS - NORMAL - NORMAL <3 NF Ǧ - - NF147 3812 39 AVD W P1L1 IUCD PRI - NORMAL BYC,PH PUS,BYC <3 NF C.ALB Ǧ - + VVC148 1739 32 AVD M P1L1 OCP PRI HRP NORMAL BYC,PH PUS,BYC,PH 3+ INT C.TROP Ǧ Ǧ - VVC149 1747 41 AVD W P3L3 TUBECT MID MSP TV - TV <3 NF TV Ǧ Ǧ - TV150 1756 28 AVD M P1L1 IUCD HSEC MSP CLUE - CLUE 3+ BV Ǧ Ǧ - BV151 1744 40 LAP M P2L2 TUBECT MID PVD NORMAL - NORMAL <3 NF Ǧ Ǧ - NF152 1765 34 AVD M P2L2 CONDOM PRI VD NORMAL BYC.PH PUS,BYC <3 INT C.KRU Ǧ Ϊ - VVC153 1761 27 AVD M P1L1 IUCD DEG MSP NORMAL - NORMAL <3 NF Ǧ Ǧ - NF154 1779 40 AVD S P2L2 CONDOM ILL FSW CLUE BYC.PH CLUE,PUS,BYC 3+ BV C.PARA Ϊ Ǧ - VVC+BV155 1755 36 AVD S P2L2 CONDOM PRI FSW NORMAL - NORMAL <3 NF TV Ǧ Ǧ - TV156 1279 26 LAP M P1L1 NIL HSEC HRP NORMAL - NORMAL <3 INT Ǧ Ǧ - NF157 1287 40 AVD S P3L3 TUBECT MID FSW CLUE BYC.PH CLUE,PUS,BYC 3+ BV C.TROP Ǧ Ǧ + VVC+BV158 1282 23 LAP UN P0L0 OCP HS FSW NORMAL BYC PUS,BYC <3 INT C.GLAB Ǧ Ǧ - VVC159 1318 30 AVD W P1L1 IUCD MID VD CLUE - CLUE 3+ BV Ϊ Ϊ - BV160 1151 41 AVD M P2L2 TUBECT MID MSP NORMAL - NORMAL <3 INT Ǧ Ǧ + NF
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161 1322 38 AVD S P2L2 TUBECT ILL FSW CLUE BYC.PH CLUE,PUS,BYC 3+ BV C.KRU Ǧ Ǧ - VVC+BV162 1323 25 AVD UN P0L0 OCP PRI FSW TV Ǧ TV <3 NF TV Ǧ Ǧ - TV163 1359 18 AVD M P0L0 OCP HSEC HRP NORMAL Ǧ NORMAL 3+ INT Ǧ Ǧ - NF164 2120 40 AVD S P2L2 CONDOM ILL FSW NORMAL BYC.PH PUS,BYC,PH <3 NF C.ALB Ǧ Ϊ + VVC165 2579 24 AVD M P0L0 OCP HS MSP CLUE Ǧ CLUE 3+ BV Ǧ Ǧ - BV166 2612 23 AVD M P0L0 OCP HSEC MSP NORMAL Ǧ NORMAL <3 INT Ǧ Ǧ - NF167 317 34 AVD M P2L2 TUBECT MID PVD NORMAL Ǧ NORMAL <3 NF Ǧ Ǧ - NF168 321 37 AVD S P2L2 CONDOM MID VD NORMAL BYC.PH PUS,BYC,PH <3 INT C.ALB Ǧ Ǧ - VVC169 349 41 LAP W P2L2 CONDOM PRI FSW CLUE,TV - CLUE 3+ BV TV Ǧ Ǧ - TV+BV170 357 31 AVD M P1L1 IUCD PRI MSP NORMAL BYC.PH PUS,BYC,PH <3 NF C.ALB Ǧ Ǧ - VVC171 360 26 AVD M P0L0 NIL HS MSP NORMAL - NORMAL <3 INT Ǧ Ǧ - NF172 367 30 AVD S P1L1 IUCD PRI FSW CLUE - CLUE 3+ BV Ǧ Ǧ - NF173 411 27 AVD M P2L2 CONDOM HS MSP NORMAL - NORMAL <3 NF Ǧ Ǧ - NF174 427 43 AVD M P2L2 CONDOM PRI VD NORMAL BYC.PH PUS,BYC,PH <3 INT C.KRU Ǧ Ϊ + VVC175 444 32 AVD M P2L2 TUBECT HSEC HRP NORMAL BYC.PH PUS,BYC,PH <3 NF C.ALB Ǧ Ǧ - VVC176 378 28 AVD UN P0L0 OCP HS MSP TV - TV 3+ INT TV Ǧ Ǧ - TV177 507 36 AVD W P3L3 CONDOM MID FSW CLUE BYC.PH CLUE,PUS,BYC 3+ BV C.ALB Ǧ Ǧ - VVC+BV178 521 34 AVD M P2L2 CONDOM HS HRP CLUE - CLUE 3+ BV Ǧ Ǧ - BV179 571 32 LAP M P1L1 IUCD PRI HRP TV - TV <3 NF TV Ǧ Ǧ - TV180 589 21 AVD UN P0L0 OCP HS MSP NORMAL BYC,PH PUS,BYC,PH <3 INT C.TROP Ǧ Ǧ - VVC181 601 39 AVD W P2L2 TUBECT MID FSW NORMAL BYC.PH PUS,BYC,PH <3 NF C.ALB Ǧ Ǧ - VVC182 606 24 LAP M P0L0 OCP HS MSP CLUE Ǧ CLUE 3+ BV Ǧ Ǧ - BV183 791 24 AVD S P0L0 CONDOM HS MSP NORMAL Ǧ NORMAL <3 NF Ǧ Ǧ - NF
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184 826 38 LAP S P0L0 CONDOM MID PVD NORMAL BYC.PH PUS,BYC,PH <3 INT C.ALB Ǧ Ǧ - VVC185 829 28 AVD M P2L2 NIL HS HRP NORMAL - NORMAL <3 NF Ǧ Ǧ - NF186 864 37 AVD M P2L2 TUBECT MID FSW CLUE BYC.PH CLUE,PUS,BYC 3+ BV C.ALB Ǧ Ǧ - VVC+BV187 870 23 AVD UN P0L0 CONDOM HS MSP NORMAL - NORMAL <3 INT Ǧ Ǧ - NF188 872 38 LAP S P2L2 TUBECT MID VD NORMAL BYC PUS,BYC <3 NF C.GLAB Ǧ Ϊ - VVC189 881 39 AVD S P3L3 NIL ILL FSW NORMAL BYC.PH PUS,BYC,PH <3 INT C.ALB Ǧ Ǧ - VVC190 892 22 AVD M P0L0 CONDOM HSEC MSP CLUE Ǧ CLUE 3+ BV Ǧ Ǧ - BV191 893 35 AVD S P2L2 CONDOM MID FSW NORMAL Ǧ NORMAL <3 NF Ǧ Ǧ - NF192 910 36 AVD W P2L2 TUBECT MID FSW NORMAL BYC.PH PUS,BYC,PH <3 INT C.TROP Ǧ Ǧ - VVC193 922 34 AVD S P2L2 CONDOM MID MSP NORMAL - NORMAL <3 NF Ǧ Ǧ - NF194 927 30 AVD M P2L2 CONDOM PRI HRP CLUE - CLUE 3+ BV Ǧ Ǧ - BV195 934 37 AVD S P2L2 TUBECT ILL FSW BYC,PH BYC.PH PUS,BYC,PH <3 NF C.ALB Ǧ Ǧ - VVC196 937 36 AVD M P3L2 TUBECT MID HRP NORMAL - NORMAL <3 INT Ǧ Ǧ - NF197 618 41 LAP W P2L2 CONDOM MID FSW NORMAL BYC PUS,BYC <3 NF C.GLAB Ǧ Ǧ - VVC198 952 39 AVD S P2L2 CONDOM PRI FSW NORMAL BYC.PH PUS,BYC,PH <3 INT C.PARA Ǧ Ǧ - VVC199 973 30 AVD M P0L0 CONDOM PRI PVD NORMAL - NORMAL <3 INT Ǧ Ǧ - NF200 985 37 AVD S P2L2 TUBECT PRI MSP CLUE BYC.PH CLUE,PUS,BYC 3+ BV C.ALB Ǧ Ǧ - VVC+BV
